| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | DHX16 KIF21B ACSL6 ATP6V1A ABCC4 MYH10 MYH11 BRIP1 HYOU1 EP400 NTPCR BTAF1 MSH3 DDX27 DHX9 MDN1 DNAI2 CCT8 KIF14 DNAH6 DNAH8 DHX29 | 2.81e-08 | 614 | 177 | 22 | GO:0140657 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | KIF21B MAGI1 MYH10 MYH11 ANK3 LRRK2 OBSCN CKAP5 ADGRV1 PRC1 DCX RCC2 ENKD1 ERMN LMOD3 ANLN WASF2 KIF14 DIXDC1 CTNNA2 RAB39B ABLIM2 USH2A NOS2 EPB41L1 MX2 | 4.58e-06 | 1099 | 177 | 26 | GO:0008092 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DHX16 KIF21B ATP6V1A ABCC4 BRIP1 NTPCR BTAF1 DDX27 DHX9 MDN1 CCT8 KIF14 DNAH6 DNAH8 DHX29 | 9.55e-06 | 441 | 177 | 15 | GO:0016887 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DHX16 KIF21B ATP6V1A ABCC4 BRIP1 NTPCR LRRK2 BTAF1 RRAS DDX27 DHX9 MDN1 CCT8 KIF14 RAB39B DNAH6 DNAH8 DHX29 MX2 | 6.11e-05 | 775 | 177 | 19 | GO:0017111 |
| GeneOntologyMolecularFunction | transaminase activity | 7.66e-05 | 26 | 177 | 4 | GO:0008483 | |
| GeneOntologyMolecularFunction | phorbol ester receptor activity | 7.81e-05 | 2 | 177 | 2 | GO:0001565 | |
| GeneOntologyMolecularFunction | non-kinase phorbol ester receptor activity | 7.81e-05 | 2 | 177 | 2 | GO:0001566 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 8.81e-05 | 118 | 177 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | transferase activity, transferring nitrogenous groups | 1.03e-04 | 28 | 177 | 4 | GO:0016769 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DHX16 KIF21B ATP6V1A ABCC4 BRIP1 NTPCR LRRK2 BTAF1 RRAS DDX27 DHX9 MDN1 CCT8 KIF14 RAB39B DNAH6 DNAH8 DHX29 MX2 | 1.72e-04 | 839 | 177 | 19 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DHX16 KIF21B ATP6V1A ABCC4 BRIP1 NTPCR LRRK2 BTAF1 RRAS DDX27 DHX9 MDN1 CCT8 KIF14 RAB39B DNAH6 DNAH8 DHX29 MX2 | 1.74e-04 | 840 | 177 | 19 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DHX16 KIF21B ATP6V1A ABCC4 BRIP1 NTPCR LRRK2 BTAF1 RRAS DDX27 DHX9 MDN1 CCT8 KIF14 RAB39B DNAH6 DNAH8 DHX29 MX2 | 1.74e-04 | 840 | 177 | 19 | GO:0016818 |
| GeneOntologyMolecularFunction | calmodulin binding | 2.19e-04 | 230 | 177 | 9 | GO:0005516 | |
| GeneOntologyMolecularFunction | cadherin binding | ANK3 OBSCN CKAP5 PPL ANLN WASF2 CCT8 CTNNA2 DHX29 NOS2 CDH11 | 2.29e-04 | 339 | 177 | 11 | GO:0045296 |
| GeneOntologyMolecularFunction | nitric-oxide synthase activity | 2.33e-04 | 3 | 177 | 2 | GO:0004517 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | ANK3 DSP L1CAM OBSCN CKAP5 DSCAML1 PPL ANLN WASF2 CCT8 CTNNA2 DHX29 NOS2 CDH11 VCAM1 | 2.99e-04 | 599 | 177 | 15 | GO:0050839 |
| GeneOntologyMolecularFunction | microtubule motor activity | 3.93e-04 | 70 | 177 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | tetrahydrobiopterin binding | 4.63e-04 | 4 | 177 | 2 | GO:0034617 | |
| GeneOntologyMolecularFunction | helicase activity | 5.30e-04 | 158 | 177 | 7 | GO:0004386 | |
| GeneOntologyMolecularFunction | RNA helicase activity | 6.47e-04 | 78 | 177 | 5 | GO:0003724 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on RNA | 7.27e-04 | 80 | 177 | 5 | GO:0008186 | |
| GeneOntologyMolecularFunction | actin binding | MYH10 MYH11 LRRK2 ERMN LMOD3 ANLN WASF2 DIXDC1 CTNNA2 ABLIM2 NOS2 EPB41L1 | 1.20e-03 | 479 | 177 | 12 | GO:0003779 |
| GeneOntologyMolecularFunction | syntaxin-1 binding | 1.21e-03 | 24 | 177 | 3 | GO:0017075 | |
| GeneOntologyMolecularFunction | microtubule binding | 1.76e-03 | 308 | 177 | 9 | GO:0008017 | |
| GeneOntologyCellularComponent | supramolecular fiber | KIF21B MYH10 MYH11 ANK3 DSP OBSCN CKAP5 PRC1 DCX RCC2 ENKD1 PPL DNAJA3 LMOD3 MFAP1 MAP1LC3C DNAI2 CCT8 KIF14 TPT1P8 ABLIM2 DNAH6 DNAH8 NOS1 MX2 | 1.91e-05 | 1179 | 176 | 25 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KIF21B MYH10 MYH11 ANK3 DSP OBSCN CKAP5 PRC1 DCX RCC2 ENKD1 PPL DNAJA3 LMOD3 MFAP1 MAP1LC3C DNAI2 CCT8 KIF14 TPT1P8 ABLIM2 DNAH6 DNAH8 NOS1 MX2 | 2.14e-05 | 1187 | 176 | 25 | GO:0099081 |
| GeneOntologyCellularComponent | anchoring junction | MPP2 MAGI1 THEMIS HYOU1 ANK3 DSP ARHGAP26 L1CAM OBSCN SRP68 RRAS PPL SLC9A5 CLCA2 WASF2 DIXDC1 PLCG1 CTNNA2 MAPK3 CDH11 SYMPK | 7.66e-05 | 976 | 176 | 21 | GO:0070161 |
| GeneOntologyCellularComponent | somatodendritic compartment | MPP2 KIF21B MYH10 ANK3 L1CAM LRRK2 CKAP5 RCVRN PHAX GRM8 DCX STAR NGDN ERMN TXNRD1 SLC9A5 ZPR1 NGF DIXDC1 USH2A NOS1 GOT2 CREB3 SOS1 | 1.03e-04 | 1228 | 176 | 24 | GO:0036477 |
| GeneOntologyCellularComponent | microtubule | KIF21B CKAP5 PRC1 DCX RCC2 ENKD1 MAP1LC3C DNAI2 CCT8 KIF14 TPT1P8 DNAH6 DNAH8 MX2 | 1.76e-04 | 533 | 176 | 14 | GO:0005874 |
| GeneOntologyCellularComponent | cell body | MYH10 L1CAM LRRK2 CKAP5 RCVRN PHAX GRM8 DCX STAR ERMN TXNRD1 PITPNM1 ZPR1 CCT8 DIXDC1 USH2A GOT2 CREB3 SOS1 | 3.25e-04 | 929 | 176 | 19 | GO:0044297 |
| GeneOntologyCellularComponent | distal axon | UNC13B KIF21B MYH10 L1CAM LRRK2 DCX ZPR1 UNC13C DIXDC1 USH2A NOS1 DCLK1 | 3.30e-04 | 435 | 176 | 12 | GO:0150034 |
| GeneOntologyCellularComponent | USH2 complex | 4.18e-04 | 4 | 176 | 2 | GO:1990696 | |
| GeneOntologyCellularComponent | photoreceptor inner segment | 5.14e-04 | 78 | 176 | 5 | GO:0001917 | |
| GeneOntologyCellularComponent | axon | UNC13B KIF21B MYH10 ANK3 L1CAM LRRK2 DCX DSCAML1 NGDN ERMN ZPR1 NGF UNC13C DIXDC1 CTNNA2 USH2A NOS1 DCLK1 | 5.41e-04 | 891 | 176 | 18 | GO:0030424 |
| GeneOntologyCellularComponent | glutamatergic synapse | UNC13B MPP2 KIF21B MYH10 L1CAM LRRK2 ANO1 GRM8 DCX NGDN DIXDC1 PLCG1 MAPK3 CADPS2 NOS1 CDH11 DCLK1 | 5.57e-04 | 817 | 176 | 17 | GO:0098978 |
| GeneOntologyCellularComponent | CBM complex | 6.93e-04 | 5 | 176 | 2 | GO:0032449 | |
| GeneOntologyCellularComponent | neuronal cell body | MYH10 L1CAM LRRK2 CKAP5 RCVRN PHAX GRM8 DCX STAR ERMN TXNRD1 ZPR1 DIXDC1 USH2A GOT2 CREB3 SOS1 | 7.10e-04 | 835 | 176 | 17 | GO:0043025 |
| GeneOntologyCellularComponent | U2-type precatalytic spliceosome | 8.91e-04 | 51 | 176 | 4 | GO:0071005 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 9.18e-04 | 23 | 176 | 3 | GO:0098831 | |
| GeneOntologyCellularComponent | cytoplasmic region | UNC13B MAK LRRK2 CKAP5 DNAI2 UNC13C CTNNA2 DNAH6 DNAH8 HYDIN | 9.83e-04 | 360 | 176 | 10 | GO:0099568 |
| GeneOntologyCellularComponent | stereocilia ankle link | 1.03e-03 | 6 | 176 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 1.03e-03 | 6 | 176 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | stereocilium membrane | 1.03e-03 | 6 | 176 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | periciliary membrane compartment | 1.03e-03 | 6 | 176 | 2 | GO:1990075 | |
| GeneOntologyCellularComponent | nuclear stress granule | 1.03e-03 | 6 | 176 | 2 | GO:0097165 | |
| GeneOntologyCellularComponent | precatalytic spliceosome | 1.11e-03 | 54 | 176 | 4 | GO:0071011 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.18e-03 | 25 | 176 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | myosin filament | 1.18e-03 | 25 | 176 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | terminal bouton | 1.32e-03 | 96 | 176 | 5 | GO:0043195 | |
| GeneOntologyCellularComponent | synaptic membrane | UNC13B MPP2 ANK3 L1CAM ANO1 GRM8 DNAJA3 SLC9A5 GPR156 UNC13C CTNNA2 CADPS2 EPB41L1 | 1.36e-03 | 583 | 176 | 13 | GO:0097060 |
| GeneOntologyCellularComponent | U2-type spliceosomal complex | 1.38e-03 | 97 | 176 | 5 | GO:0005684 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KIF21B DSP CKAP5 PRC1 DCX RCC2 ENKD1 PPL DNAJA3 MAP1LC3C DNAI2 CCT8 KIF14 TPT1P8 DNAH6 DNAH8 MX2 | 1.58e-03 | 899 | 176 | 17 | GO:0099513 |
| GeneOntologyCellularComponent | stereocilia coupling link | 1.91e-03 | 8 | 176 | 2 | GO:0002139 | |
| GeneOntologyCellularComponent | axon terminus | 2.06e-03 | 210 | 176 | 7 | GO:0043679 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 2.07e-03 | 332 | 176 | 9 | GO:0005788 | |
| GeneOntologyCellularComponent | microtubule associated complex | 2.46e-03 | 161 | 176 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | neuromuscular junction | 2.60e-03 | 112 | 176 | 5 | GO:0031594 | |
| GeneOntologyCellularComponent | midbody | 2.81e-03 | 222 | 176 | 7 | GO:0030496 | |
| GeneOntologyCellularComponent | calyx of Held | 3.42e-03 | 36 | 176 | 3 | GO:0044305 | |
| GeneOntologyCellularComponent | neuron projection terminus | 3.66e-03 | 233 | 176 | 7 | GO:0044306 | |
| Domain | P-loop_NTPase | DHX16 MPP2 KIF21B MAGI1 ATP6V1A ABCC4 MYH10 MYH11 BRIP1 EP400 NTPCR LRRK2 BTAF1 MSH3 RRAS DDX27 DHX9 SAMD9L NWD2 MDN1 GIMAP8 KIF14 CARD11 RAB39B DNAH6 DNAH8 DHX29 HYDIN MX2 | 1.58e-09 | 848 | 176 | 29 | IPR027417 |
| Domain | - | DHX16 MPP2 ATP6V1A ABCC4 BRIP1 EP400 NTPCR LRRK2 BTAF1 MSH3 RRAS DDX27 DHX9 SAMD9L NWD2 MDN1 GIMAP8 CARD11 RAB39B DNAH6 DNAH8 DHX29 HYDIN MX2 | 1.48e-07 | 746 | 176 | 24 | 3.40.50.300 |
| Domain | DUF1041 | 8.11e-06 | 5 | 176 | 3 | SM01145 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 1.81e-05 | 35 | 176 | 5 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 2.74e-05 | 38 | 176 | 5 | PS00690 | |
| Domain | Munc13_1 | 2.80e-05 | 7 | 176 | 3 | IPR014770 | |
| Domain | MHD1 | 2.80e-05 | 7 | 176 | 3 | PS51258 | |
| Domain | DUF1041 | 2.80e-05 | 7 | 176 | 3 | PF06292 | |
| Domain | CAPS_dom | 2.80e-05 | 7 | 176 | 3 | IPR010439 | |
| Domain | DEXDc | 7.78e-05 | 109 | 176 | 7 | SM00487 | |
| Domain | Helicase_ATP-bd | 8.24e-05 | 110 | 176 | 7 | IPR014001 | |
| Domain | TRPV5/TRPV6 | 8.83e-05 | 2 | 176 | 2 | IPR008344 | |
| Domain | NO_synthase | 2.63e-04 | 3 | 176 | 2 | PF02898 | |
| Domain | NOS_euk | 2.63e-04 | 3 | 176 | 2 | IPR012144 | |
| Domain | - | 2.63e-04 | 3 | 176 | 2 | 3.90.340.10 | |
| Domain | Unc-13 | 2.63e-04 | 3 | 176 | 2 | IPR027080 | |
| Domain | NOS_N | 2.63e-04 | 3 | 176 | 2 | IPR004030 | |
| Domain | NOS | 2.63e-04 | 3 | 176 | 2 | PS60001 | |
| Domain | ATPase_dyneun-rel_AAA | 2.77e-04 | 14 | 176 | 3 | IPR011704 | |
| Domain | AAA_5 | 2.77e-04 | 14 | 176 | 3 | PF07728 | |
| Domain | DUF1605 | 5.08e-04 | 17 | 176 | 3 | IPR011709 | |
| Domain | OB_NTP_bind | 5.08e-04 | 17 | 176 | 3 | PF07717 | |
| Domain | CABIT | 5.23e-04 | 4 | 176 | 2 | PF12736 | |
| Domain | CABIT_dom | 5.23e-04 | 4 | 176 | 2 | IPR025946 | |
| Domain | Helicase_C | 5.29e-04 | 107 | 176 | 6 | PF00271 | |
| Domain | HELICc | 5.29e-04 | 107 | 176 | 6 | SM00490 | |
| Domain | Helicase_C | 5.56e-04 | 108 | 176 | 6 | IPR001650 | |
| Domain | HELICASE_CTER | 5.84e-04 | 109 | 176 | 6 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 5.84e-04 | 109 | 176 | 6 | PS51192 | |
| Domain | HA2 | 6.05e-04 | 18 | 176 | 3 | SM00847 | |
| Domain | HA2 | 6.05e-04 | 18 | 176 | 3 | PF04408 | |
| Domain | Helicase-assoc_dom | 6.05e-04 | 18 | 176 | 3 | IPR007502 | |
| Domain | Munc13_dom-2 | 8.67e-04 | 5 | 176 | 2 | IPR014772 | |
| Domain | MHD2 | 8.67e-04 | 5 | 176 | 2 | PS51259 | |
| Domain | Munc13_subgr_dom-2 | 8.67e-04 | 5 | 176 | 2 | IPR019558 | |
| Domain | Myosin_S1_N | 8.67e-04 | 5 | 176 | 2 | IPR008989 | |
| Domain | Membr_traf_MHD | 8.67e-04 | 5 | 176 | 2 | PF10540 | |
| Domain | GUANYLATE_KINASE_2 | 1.27e-03 | 23 | 176 | 3 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 1.27e-03 | 23 | 176 | 3 | PS00856 | |
| Domain | DCX | 1.29e-03 | 6 | 176 | 2 | SM00537 | |
| Domain | FAD_binding_1 | 1.29e-03 | 6 | 176 | 2 | PF00667 | |
| Domain | - | 1.29e-03 | 6 | 176 | 2 | 1.20.990.10 | |
| Domain | FAD-binding_1 | 1.29e-03 | 6 | 176 | 2 | IPR003097 | |
| Domain | NADPH_Cyt_P450_Rdtase_dom3 | 1.29e-03 | 6 | 176 | 2 | IPR023173 | |
| Domain | ARM-type_fold | RALGAPA1 DOCK11 LRRK2 CKAP5 KPNA6 BTAF1 SIL1 PSME4 PIK3CD SYMPK | 1.45e-03 | 339 | 176 | 10 | IPR016024 |
| Domain | - | 1.80e-03 | 7 | 176 | 2 | 3.10.20.230 | |
| Domain | Plectin | 1.80e-03 | 7 | 176 | 2 | PF00681 | |
| Domain | CUT | 1.80e-03 | 7 | 176 | 2 | PS51042 | |
| Domain | CUT | 1.80e-03 | 7 | 176 | 2 | PF02376 | |
| Domain | Plectin_repeat | 1.80e-03 | 7 | 176 | 2 | IPR001101 | |
| Domain | DCX | 1.80e-03 | 7 | 176 | 2 | PF03607 | |
| Domain | CUT_dom | 1.80e-03 | 7 | 176 | 2 | IPR003350 | |
| Domain | CUT | 1.80e-03 | 7 | 176 | 2 | SM01109 | |
| Domain | PLEC | 1.80e-03 | 7 | 176 | 2 | SM00250 | |
| Domain | Ig_I-set | 2.19e-03 | 190 | 176 | 7 | IPR013098 | |
| Domain | I-set | 2.19e-03 | 190 | 176 | 7 | PF07679 | |
| Domain | Flavodoxin/NO_synth | 2.38e-03 | 8 | 176 | 2 | IPR008254 | |
| Domain | Flavdoxin-like | 2.38e-03 | 8 | 176 | 2 | IPR001094 | |
| Domain | DC | 2.38e-03 | 8 | 176 | 2 | PS50309 | |
| Domain | FLAVODOXIN_LIKE | 2.38e-03 | 8 | 176 | 2 | PS50902 | |
| Domain | Flavodoxin_1 | 2.38e-03 | 8 | 176 | 2 | PF00258 | |
| Domain | Doublecortin_dom | 2.38e-03 | 8 | 176 | 2 | IPR003533 | |
| Pathway | PID_TRKR_PATHWAY | 2.93e-05 | 61 | 139 | 6 | M187 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_CIT | 3.13e-05 | 19 | 139 | 4 | M27489 | |
| Pathway | BIOCARTA_NGF_PATHWAY | 3.88e-05 | 20 | 139 | 4 | M7860 | |
| Pathway | BIOCARTA_NGF_PATHWAY | 5.77e-05 | 22 | 139 | 4 | MM1440 | |
| Pathway | WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS | 8.25e-05 | 24 | 139 | 4 | M39850 | |
| Pubmed | MPP2 RALGAPA1 ACSL6 ATP6V1A MYH10 MYH11 HYOU1 ANK3 DSP ARHGAP26 L1CAM CKAP5 FARSB SRP68 PTGS2 LUZP1 DHX9 ERMN PITPNM1 TARS3 NWD2 CCT8 CTNNA2 MAPK3 ABLIM2 DNAH6 DHX29 NOS1 DCLK1 EPB41L1 GOT2 RPL13 | 3.15e-12 | 1431 | 181 | 32 | 37142655 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DHX16 MYH10 HYOU1 DSP ECD CKAP5 FARSB SRP68 PRC1 PRPF8 F5 DDX27 RCC2 GTF3C4 ISY1 PPL LUZP1 DHX9 NGDN DNAJA3 MFAP1 PRPF3 ANLN MKI67 RBM15B CCT8 KIF14 RPL13 DNMT1 | 1.78e-11 | 1257 | 181 | 29 | 36526897 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DHX16 MYH10 EP400 DSP GPX8 CKAP5 FARSB SRP68 MSH3 PRPF8 DDX27 GTF3C4 LUZP1 DHX9 NGDN DNAJA3 MFAP1 MDN1 FAF2 PSME4 PRPF3 ANLN MKI67 CCT8 PLCG1 DHX29 GOT2 CCDC93 RPL13 DNMT1 | 2.03e-11 | 1353 | 181 | 30 | 29467282 |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | DHX16 ATP6V1A BRIP1 ACACB EP400 DSP FARSB MSH3 RCC2 DHX9 PRPF3 MKI67 CCT8 SLX4IP RPL13 SYMPK | 7.52e-11 | 357 | 181 | 16 | 37059091 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EHBP1 ATP6V1A MYH10 ACACB EP400 DSP ECD CKAP5 FARSB SRP68 BTAF1 PHAX PRPF8 RCC2 GTF3C4 PRPF3 WASF2 MKI67 CCT8 PLCG1 DHX29 RPL13 DNMT1 | 7.76e-10 | 934 | 181 | 23 | 33916271 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | DHX16 BRIP1 EP400 JADE3 DSP CKAP5 BTAF1 GTF3C4 PPL DHX9 PITPNM1 MFAP1 MDN1 ANLN MKI67 RBM15B MAPK3 DHX29 DNMT1 SYMPK SOS1 | 8.11e-10 | 774 | 181 | 21 | 15302935 |
| Pubmed | MYH10 BRIP1 HYOU1 ANK3 FARSB SRP68 KPNA6 SMG5 MSH3 DDX27 GTF3C4 DHX9 DNAJA3 MDN1 MKI67 OS9 CTNNA2 EPB41L1 STOM | 1.08e-09 | 634 | 181 | 19 | 34591612 | |
| Pubmed | MPP2 KIF21B MAGI1 MYH10 MAGED1 ANK3 DOCK11 CKAP5 FARSB DCX LUZP1 MDN1 WASF2 DZIP3 CCT8 DIXDC1 CTNNA2 MAPK3 NOS1 CDH11 DCLK1 EPB41L1 DNMT1 | 1.39e-09 | 963 | 181 | 23 | 28671696 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DHX16 ATP6V1A MYH10 HYOU1 DSP CKAP5 FARSB SRP68 KPNA6 MSH3 PRC1 PRPF8 DDX27 RCC2 DHX9 DNAJA3 MDN1 FAF2 CLCA2 MKI67 RBM15B CCT8 KIF14 PLCG1 DHX29 GOT2 RPL13 DNMT1 | 1.54e-09 | 1425 | 181 | 28 | 30948266 |
| Pubmed | MAGED1 CKAP5 FARSB SRP68 BTAF1 PRC1 PHAX PRPF8 SKP2 DDX27 RCC2 GTF3C4 DHX9 TXNRD1 DNAJA3 CKM PRPF3 CCT8 UNC13C CTNNA2 DHX29 RPL13 DNMT1 | 1.63e-09 | 971 | 181 | 23 | 33306668 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | HYOU1 GPX8 ARHGAP26 ECD CKAP5 FARSB KPNA6 PRPF8 DDX27 RCC2 PPL SIL1 LUZP1 FAF2 KCTD3 CCT8 TXNDC16 OS9 PLCG1 MAPK3 DHX29 RPL13 | 8.92e-09 | 974 | 181 | 22 | 28675297 |
| Pubmed | DHX16 MYH10 EP400 FARSB KPNA6 PHAX RCC2 GTF3C4 ISY1 LUZP1 MFAP1 PRPF3 ANLN WASF2 MKI67 CCT8 | 1.13e-08 | 506 | 181 | 16 | 30890647 | |
| Pubmed | ATP6V1A MYH10 RMND5A MAGED1 HYOU1 GPX8 ECD FARSB HMGCR BTAF1 PRPF8 FHIP2A SKP2 DDX27 RCC2 MDN1 FAF2 PRPF3 MKI67 CCT8 KIF14 OS9 CTNNA2 STX17 DHX29 CCDC93 | 3.47e-08 | 1440 | 181 | 26 | 30833792 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | DHX16 ATP6V1A MYH10 MAGED1 HYOU1 DSP ECD FARSB SRP68 PRPF8 LUZP1 DHX9 KCTD3 CCT8 RPL13 | 3.55e-08 | 477 | 181 | 15 | 31300519 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | CKAP5 FARSB SRP68 PRC1 PHAX PRPF8 DDX27 RCC2 GTF3C4 DHX9 NGDN MDN1 PRPF3 MKI67 RBM15B DHX29 RPL13 DNMT1 | 1.06e-07 | 759 | 181 | 18 | 35915203 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | KIF21B ATP6V1A MYH10 MYH11 DSP GPX8 ECD CKAP5 PRC1 PRPF8 TMEM200A CKM MDN1 CCT8 DNAH6 DHX29 CCDC93 RPL13 DNMT1 | 1.09e-07 | 847 | 181 | 19 | 35235311 |
| Pubmed | Neuronal NOS and cyclooxygenase-2 contribute to DNA damage in a mouse model of Parkinson disease. | 1.39e-07 | 3 | 181 | 3 | 19616617 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EP400 CKAP5 FARSB SRP68 MSH3 PRC1 PRPF8 GTF3C4 MDN1 ANLN DNMT1 SYMPK | 1.98e-07 | 332 | 181 | 12 | 32786267 |
| Pubmed | MAGED1 EP400 NTPCR CKAP5 FARSB SRP68 RRAS DDX27 RCC2 LUZP1 NGDN ZNF800 MDN1 ANLN WASF2 KCTD3 RBM15B CCT8 KIF14 OS9 CTNNA2 DHX29 DCLK1 EPB41L1 STOM | 2.84e-07 | 1497 | 181 | 25 | 31527615 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | DHX16 MYH10 EP400 PHAX GTF3C4 DHX9 MFAP1 PRPF3 MKI67 CCT8 DNMT1 | 3.15e-07 | 283 | 181 | 11 | 30585729 |
| Pubmed | DHX16 ATP6V1A MYH10 HYOU1 DSP GPX8 L1CAM FARSB SRP68 KPNA6 PRPF8 LUZP1 DHX9 NGDN CKM ANLN MKI67 CCT8 OS9 CTNNA2 GOT2 STOM DNMT1 | 3.17e-07 | 1297 | 181 | 23 | 33545068 | |
| Pubmed | MYH10 DSP FARSB SRP68 PRC1 PRPF8 DDX27 RCC2 ISY1 DHX9 NGDN DNAJA3 MFAP1 PRPF3 RBM15B CCT8 RPL13 | 3.21e-07 | 731 | 181 | 17 | 29298432 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | HYOU1 ACACB NTPCR CKAP5 KPNA6 PRPF8 DNAJA3 PRR14 KCTD3 MKI67 CCT8 MAPK3 HERC1 GOT2 DOP1B | 3.75e-07 | 573 | 181 | 15 | 28330616 |
| Pubmed | KIF21B ATP6V1A MYH10 KPNA6 MSH3 PRC1 PRPF8 F5 RCC2 LUZP1 DHX9 MFAP1 PRPF3 ANLN MKI67 KIF14 | 4.20e-07 | 660 | 181 | 16 | 32780723 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DHX16 ATP6V1A HYOU1 EP400 DSP CKAP5 BTAF1 PRPF8 F5 DDX27 RCC2 DHX9 MFAP1 MDN1 PRPF3 MKI67 CCT8 KIF14 GOT2 RPL13 | 4.49e-07 | 1024 | 181 | 20 | 24711643 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | UNC13B ANK3 CKAP5 F5 NGDN SAMD9L RBM15B KIF14 CARD11 CADPS2 DNAH6 RPL13 | 4.82e-07 | 361 | 181 | 12 | 26167880 |
| Pubmed | 5.52e-07 | 4 | 181 | 3 | 8914934 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | DHX16 MYH10 EP400 DSP CKAP5 FARSB KPNA6 BTAF1 SMG5 MSH3 PRC1 PRPF8 SKP2 GTF3C4 MDN1 WASF2 STOM SYMPK | 6.24e-07 | 857 | 181 | 18 | 25609649 |
| Pubmed | RALGAPA1 MYH10 HYOU1 ANK3 DSP KPNA6 DDX27 LUZP1 DNAJA3 PRPF3 KCTD3 MKI67 KIF14 MAPK3 HERC1 STX17 EPB41L1 RPL13 DNMT1 SYMPK | 6.53e-07 | 1049 | 181 | 20 | 27880917 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | BRIP1 EP400 DSP NTPCR FARSB PRPF8 RCC2 ISY1 LUZP1 DHX9 MFAP1 PRPF3 ANLN MKI67 RBM15B CCT8 SLX4IP DNMT1 SYMPK | 6.63e-07 | 954 | 181 | 19 | 36373674 |
| Pubmed | UNC13B DHX16 ATP6V1A MYH10 MYH11 EP400 DSP FARSB SRP68 PHAX PRPF8 DDX27 GTF3C4 LUZP1 NGDN MFAP1 MKI67 RBM15B CCT8 CTNNA2 MX2 STOM DNMT1 | 8.24e-07 | 1371 | 181 | 23 | 36244648 | |
| Pubmed | RALGAPA1 ATP6V1A RMND5A GPX8 KPNA6 RCC2 ENKD1 GTF3C4 PRPF3 CCT8 OS9 MAPK3 DHX29 DNMT1 | 8.94e-07 | 533 | 181 | 14 | 25544563 | |
| Pubmed | 1.03e-06 | 35 | 181 | 5 | 24515614 | ||
| Pubmed | UNC13B MAGED1 ANK3 DSP CKAP5 KPNA6 SMG5 MSH3 PRPF8 DDX27 DSCAML1 GTF3C4 TARS3 PLCG1 GFPT2 TNKS2 CADPS2 DCLK1 RPL13 DNMT1 DOP1B SOS1 | 1.05e-06 | 1285 | 181 | 22 | 35914814 | |
| Pubmed | RALGAPA1 EHBP1 MAGI1 HYOU1 ANK3 DSP CKAP5 FARSB SRP68 RCC2 DHX9 WASF2 CCT8 DHX29 EPB41L1 RPL13 | 1.05e-06 | 708 | 181 | 16 | 39231216 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | EP400 JADE3 DSP CKAP5 MSH3 PRC1 PRPF8 RCC2 GTF3C4 ISY1 DHX9 NGDN DNAJA3 MFAP1 MDN1 PRPF3 MKI67 RBM15B STOM RPL13 DNMT1 SYMPK | 1.17e-06 | 1294 | 181 | 22 | 30804502 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ATP6V1A MYH10 MYH11 HYOU1 ANK3 DSP PRPF8 TMEM200A GTF3C4 DHX9 TXNRD1 MDN1 FAF2 CCT8 HYDIN GOT2 STOM | 1.25e-06 | 807 | 181 | 17 | 30575818 |
| Pubmed | DHX16 ATP6V1A EP400 FARSB MSH3 PRC1 PHAX PRPF8 GTF3C4 ISY1 DHX9 TXNRD1 MFAP1 MDN1 PRPF3 MKI67 CCT8 DNMT1 SYMPK | 1.63e-06 | 1014 | 181 | 19 | 32416067 | |
| Pubmed | UNC13B DHX16 ACSL6 MYH10 EP400 CKAP5 FHIP2A KANK1 FAF2 DZIP3 EPB41L1 DOP1B | 1.69e-06 | 407 | 181 | 12 | 12693553 | |
| Pubmed | DHX16 MYH10 SRP68 BTAF1 PHAX PRPF8 DDX27 RCC2 DHX9 MFAP1 FAF2 PRPF3 PLCG1 GFPT2 DNMT1 | 1.90e-06 | 653 | 181 | 15 | 33742100 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | ATP6V1A MYH10 MAGED1 HYOU1 ANK3 DSP CKAP5 FARSB SRP68 KPNA6 PRPF8 RCC2 LUZP1 DHX9 DNAJA3 MDN1 WASF2 CCT8 RPL13 SYMPK | 2.62e-06 | 1149 | 181 | 20 | 35446349 |
| Pubmed | DNA Methyltransferase 1 Is Indispensable for Development of the Hippocampal Dentate Gyrus. | 2.74e-06 | 6 | 181 | 3 | 27251626 | |
| Pubmed | RALGAPA1 MAGI1 ACSL6 ARHGAP26 SRP68 ADGRV1 LUZP1 DNAJA3 NWD2 KCTD3 MAPK3 EPB41L1 | 2.97e-06 | 430 | 181 | 12 | 32581705 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RALGAPA1 EHBP1 MAGI1 DOCK11 DSP CKAP5 ENKD1 LUZP1 FSIP2 VPS13D MDN1 ANLN KIF14 DCLK1 EPB41L1 DNMT1 DOP1B | 2.97e-06 | 861 | 181 | 17 | 36931259 |
| Pubmed | ATP6V1A ACACB ANK3 EP400 LRRK2 PCDHB2 SRP68 PPL DHX9 FAF2 WASF2 MKI67 CCT8 STOM RPL13 DNMT1 | 3.47e-06 | 777 | 181 | 16 | 35844135 | |
| Pubmed | Activated Braf induces esophageal dilation and gastric epithelial hyperplasia in mice. | 3.73e-06 | 45 | 181 | 5 | 28973166 | |
| Pubmed | Defining human ERAD networks through an integrative mapping strategy. | 3.75e-06 | 173 | 181 | 8 | 22119785 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | MYH10 DSP SRP68 KPNA6 PRPF8 DDX27 DHX9 NGDN MFAP1 MDN1 PRPF3 MKI67 RBM15B RPL13 | 3.89e-06 | 605 | 181 | 14 | 28977666 |
| Pubmed | 4.33e-06 | 300 | 181 | 10 | 28561026 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | DHX16 NTPCR FARSB KPNA6 MSH3 PRPF8 GTF3C4 DHX9 FAF2 ANLN CCT8 PLCG1 DNAH8 DHX29 DNMT1 | 4.72e-06 | 704 | 181 | 15 | 29955894 |
| Pubmed | Exons 5-15 of kazrin are dispensable for murine epidermal morphogenesis and homeostasis. | 4.78e-06 | 7 | 181 | 3 | 22513779 | |
| Pubmed | 4.78e-06 | 7 | 181 | 3 | 28292896 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ATP6V1A MYH10 HYOU1 DSP ECD NTPCR CKAP5 FARSB SRP68 KPNA6 PRPF8 RCC2 ISY1 DHX9 TXNRD1 DNAJA3 FAF2 PRPF3 WASF2 CCT8 RPL13 DNMT1 | 4.95e-06 | 1415 | 181 | 22 | 28515276 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | DHX16 ATP6V1A MYH10 HYOU1 ACACB EP400 FARSB SRP68 KPNA6 PRPF8 DDX27 DHX9 NGDN DNAJA3 MFAP1 MDN1 MKI67 CCT8 STOM RPL13 DNMT1 | 5.69e-06 | 1318 | 181 | 21 | 30463901 |
| Pubmed | 5.82e-06 | 23 | 181 | 4 | 28036337 | ||
| Pubmed | MYH10 MAGED1 HYOU1 NTPCR FARSB PHAX PRPF8 GTF3C4 DHX9 DNAJA3 MDN1 PRPF3 CCT8 HSD17B11 RPL13 | 6.70e-06 | 725 | 181 | 15 | 27025967 | |
| Pubmed | EHBP1 NTPCR CKAP5 SRP68 KPNA6 PRPF8 DHX9 PRPF3 ANLN CCT8 TAF13 | 7.02e-06 | 390 | 181 | 11 | 17643375 | |
| Pubmed | ATP6V1A MYH10 HYOU1 NTPCR CKAP5 SRP68 KPNA6 PRPF8 RCC2 DHX9 MDN1 FAF2 CCT8 SYMPK | 7.11e-06 | 638 | 181 | 14 | 33239621 | |
| Pubmed | DHX16 MYH10 DSP FARSB PRPF8 DDX27 DHX9 NGDN FAF2 PRPF3 MKI67 CCT8 RPL13 DNMT1 | 7.49e-06 | 641 | 181 | 14 | 36057605 | |
| Pubmed | Unconventional molecular regulation of synaptic vesicle replenishment in cochlear inner hair cells. | 7.62e-06 | 8 | 181 | 3 | 25609709 | |
| Pubmed | RALGAPA1 BRIP1 MAGED1 HYOU1 EP400 SRP68 HMGCR GTF3C4 SLC35D1 MFAP1 KANK1 ANLN KIF14 OS9 DNMT1 | 7.63e-06 | 733 | 181 | 15 | 34672954 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | DOCK11 DSP OBSCN CKAP5 SRP68 PRPF8 DSCAML1 DHX9 SAMD9L MDN1 GIMAP8 PCIF1 CCT8 DOP1B SYMPK | 8.01e-06 | 736 | 181 | 15 | 29676528 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | MAGED1 DOCK11 DSP FARSB SMG5 F5 RCC2 DHX9 NWD2 DZIP3 DHX29 DNMT1 | 8.14e-06 | 475 | 181 | 12 | 31040226 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 8.61e-06 | 256 | 181 | 9 | 33397691 | |
| Pubmed | DHX16 MYH10 HYOU1 DSP CKAP5 SRP68 PRPF8 DDX27 RCC2 MDN1 MKI67 KIF14 DNMT1 SYMPK | 9.23e-06 | 653 | 181 | 14 | 22586326 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | EHBP1 MAGI1 ANK3 CKAP5 PPL LUZP1 NGDN ANLN WASF2 CCT8 CTNNA2 DHX29 EPB41L1 | 9.24e-06 | 565 | 181 | 13 | 25468996 |
| Pubmed | MAGED1 DSP NTPCR SRP68 PRPF8 DDX27 RCC2 GTF3C4 DHX9 DNAJA3 MFAP1 ZNF800 MKI67 RPL13 | 9.55e-06 | 655 | 181 | 14 | 35819319 | |
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | 9.71e-06 | 329 | 181 | 10 | 34316702 | |
| Pubmed | ATP6V1A MYH10 HYOU1 FARSB PRPF8 DDX27 RCC2 DHX9 DNAJA3 MDN1 CCT8 RPL13 | 9.82e-06 | 484 | 181 | 12 | 31995728 | |
| Pubmed | 9.97e-06 | 330 | 181 | 10 | 32529326 | ||
| Pubmed | MYH10 SRP68 PRPF8 DDX27 GTF3C4 ISY1 LUZP1 DHX9 NGDN MFAP1 MDN1 PRPF3 MKI67 RBM15B RPL13 SYMPK | 1.02e-05 | 847 | 181 | 16 | 35850772 | |
| Pubmed | 1.02e-05 | 331 | 181 | 10 | 29199018 | ||
| Pubmed | EHBP1 MAGI1 MYH10 MYH11 ANK3 DSP KPNA6 DDX27 ENKD1 OS9 ABLIM2 SOS1 | 1.02e-05 | 486 | 181 | 12 | 20936779 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MYH10 MYH11 DSP SRP68 PRC1 PRPF8 DDX27 RCC2 LUZP1 DHX9 NGDN MAP1LC3C PRPF3 MKI67 CCT8 GFPT2 RPL13 | 1.06e-05 | 949 | 181 | 17 | 36574265 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | RALGAPA1 ATP6V1A RMND5A HYOU1 KPNA6 DDX27 SIL1 NGDN TXNRD1 MDN1 OS9 MAPK3 STOM CCDC93 DNMT1 | 1.07e-05 | 754 | 181 | 15 | 33060197 |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | ATP6V1A MYH10 HYOU1 ACACB CKAP5 FARSB SRP68 PRPF8 RCC2 DHX9 CCT8 GFPT2 STOM DNMT1 | 1.13e-05 | 665 | 181 | 14 | 30457570 |
| Pubmed | 1.14e-05 | 9 | 181 | 3 | 16387639 | ||
| Pubmed | 1.14e-05 | 9 | 181 | 3 | 28705869 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 1.17e-05 | 202 | 181 | 8 | 33005030 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | KIF21B ACACB ANK3 DOCK11 OBSCN KPNA6 PRPF8 GTF3C4 VPS13D MDN1 HERC1 HYDIN | 1.28e-05 | 497 | 181 | 12 | 36774506 |
| Pubmed | MPP2 MAGED1 GPX8 ECD MLYCD TARS3 MDN1 FAF2 TXNDC16 OS9 PLCG1 MAPK3 HSD17B11 STX17 | 1.60e-05 | 686 | 181 | 14 | 28380382 | |
| Pubmed | 1.61e-05 | 277 | 181 | 9 | 30745168 | ||
| Pubmed | Evolutionarily conserved regulators of tau identify targets for new therapies. | ATP6V1A HYOU1 GPX8 NTPCR SRP68 FAF2 CCT8 OS9 PACC1 RAB39B HSD17B11 STOM | 1.85e-05 | 516 | 181 | 12 | 36610398 |
| Pubmed | 2.11e-05 | 360 | 181 | 10 | 33111431 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | EP400 DOCK11 KPNA6 PRC1 DDX27 GTF3C4 DHX9 PRPF3 MKI67 GFPT2 DHX29 | 2.15e-05 | 440 | 181 | 11 | 34244565 |
| Pubmed | Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2. | 2.29e-05 | 161 | 181 | 7 | 32572027 | |
| Pubmed | MYH10 RMND5A DSP CKAP5 SRP68 PRC1 PRPF8 RCC2 DHX9 NGDN MDN1 FAF2 CCT8 PLCG1 RPL13 | 2.41e-05 | 809 | 181 | 15 | 32129710 | |
| Pubmed | MYH10 PHAX PRPF8 RCC2 GTF3C4 ISY1 DHX9 DNAJA3 PRPF3 MKI67 RBM15B DHX29 RPL13 SYMPK | 2.44e-05 | 713 | 181 | 14 | 29802200 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | MPP2 KIF21B ACSL6 ATP6V1A MYH10 MYH11 DCX DHX9 CCT8 RAB39B NOS1 DCLK1 GOT2 | 2.49e-05 | 621 | 181 | 13 | 22794259 |
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | ATP6V1A MYH10 MAGED1 ACACB NTPCR KPNA6 PRPF8 DDX27 DHX9 MFAP1 MDN1 CCT8 RPL13 | 2.61e-05 | 624 | 181 | 13 | 33729478 |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 20178461 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 22354706 | ||
| Pubmed | Diverse calcium channel types are present in the human placental syncytiotrophoblast basal membrane. | 2.69e-05 | 2 | 181 | 2 | 16564089 | |
| Pubmed | Endogenous expression of TRPV5 and TRPV6 calcium channels in human leukemia K562 cells. | 2.69e-05 | 2 | 181 | 2 | 19295174 | |
| Pubmed | Human TRPV5 and TRPV6: key players in cadmium and zinc toxicity. | 2.69e-05 | 2 | 181 | 2 | 23968883 | |
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 22014124 | ||
| Pubmed | 2.69e-05 | 2 | 181 | 2 | 33208464 | ||
| Pubmed | Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. | 2.69e-05 | 2 | 181 | 2 | 16373578 | |
| Pubmed | TRPV5 and TRPV6 are expressed in placenta and bone tissues during pregnancy in mice. | 2.69e-05 | 2 | 181 | 2 | 30916584 | |
| Pubmed | The role of nitric oxide synthases in the sleep responses to tumor necrosis factor-alpha. | 2.69e-05 | 2 | 181 | 2 | 15157956 | |
| Interaction | KCTD13 interactions | MPP2 RALGAPA1 ACSL6 ATP6V1A MYH10 MYH11 MAGED1 HYOU1 ANK3 DSP ARHGAP26 L1CAM CKAP5 FARSB SRP68 PTGS2 LUZP1 DHX9 ERMN PITPNM1 TARS3 NWD2 CCT8 CTNNA2 GFPT2 MAPK3 ABLIM2 DNAH6 DHX29 NOS1 DCLK1 EPB41L1 GOT2 RPL13 | 3.49e-08 | 1394 | 175 | 34 | int:KCTD13 |
| Interaction | BRCA1 interactions | MYH10 BRIP1 HYOU1 DSP OBSCN CKAP5 FARSB SRP68 KPNA6 MSH3 PRC1 SKP2 GTF3C4 LUZP1 DHX9 DNAJA3 MDN1 PRPF3 ANLN MKI67 DZIP3 CCT8 SLX4IP OS9 MAPK3 HERC1 TNKS2 USH2A DNMT1 | 1.14e-06 | 1249 | 175 | 29 | int:BRCA1 |
| Interaction | SLX4 interactions | DHX16 ATP6V1A BRIP1 ACACB EP400 DSP FARSB MSH3 RCC2 DHX9 MFAP1 MDN1 PRPF3 MKI67 CCT8 SLX4IP RPL13 SYMPK | 2.64e-06 | 572 | 175 | 18 | int:SLX4 |
| Interaction | SNRNP40 interactions | DHX16 BRIP1 ACACB EP400 JADE3 ECD LRRK2 KPNA6 PRC1 PHAX PRPF8 DDX27 RCC2 ISY1 PRPF3 ANLN MKI67 CCT8 TNKS2 | 2.99e-06 | 637 | 175 | 19 | int:SNRNP40 |
| Interaction | PTGS2 interactions | 3.57e-06 | 48 | 175 | 6 | int:PTGS2 | |
| Interaction | NAA40 interactions | DHX16 EHBP1 ATP6V1A MYH10 ACACB EP400 DSP ECD CKAP5 FARSB SRP68 BTAF1 PHAX PRPF8 RCC2 GTF3C4 PRPF3 WASF2 MKI67 CCT8 PLCG1 DHX29 RPL13 DNMT1 | 4.22e-06 | 978 | 175 | 24 | int:NAA40 |
| Interaction | LRRC59 interactions | EHBP1 ATP6V1A MYH11 MAK HYOU1 GPX8 LRRK2 CKAP5 SRP68 PRPF8 DDX27 SIL1 DHX9 MDN1 FAF2 PRPF3 ANLN TXNDC16 OS9 HSD17B11 DHX29 RPL13 | 4.34e-06 | 845 | 175 | 22 | int:LRRC59 |
| Interaction | FZR1 interactions | MAK MAGED1 CKAP5 FARSB SRP68 BTAF1 PRC1 PHAX PRPF8 SKP2 DDX27 RCC2 GTF3C4 DHX9 TXNRD1 DNAJA3 CKM PRPF3 ANLN CCT8 KIF14 UNC13C CTNNA2 DHX29 RPL13 DNMT1 | 9.88e-06 | 1172 | 175 | 26 | int:FZR1 |
| Interaction | YWHAG interactions | RALGAPA1 EHBP1 KIF21B MAGI1 ATP6V1A MYH10 DOCK11 DSP LRRK2 CKAP5 PRC1 DDX27 ENKD1 LUZP1 MFAP1 VPS13D KANK1 MDN1 ANLN WASF2 RBM15B KIF14 MAPK3 NOS2 DCLK1 EPB41L1 DNMT1 | 1.03e-05 | 1248 | 175 | 27 | int:YWHAG |
| Interaction | IFI16 interactions | DHX16 OBSCN CKAP5 SRP68 DDX27 RCC2 GTF3C4 DHX9 NGDN PRPF3 ANLN MKI67 CCT8 KIF14 MAPK3 DTHD1 DHX29 RPL13 DNMT1 | 1.51e-05 | 714 | 175 | 19 | int:IFI16 |
| Interaction | KCNA3 interactions | RALGAPA1 EHBP1 MAGI1 HYOU1 ANK3 DSP LRRK2 CKAP5 FARSB SRP68 RCC2 PPL LUZP1 DHX9 FAF2 WASF2 CCT8 CARD11 DHX29 EPB41L1 RPL13 | 2.30e-05 | 871 | 175 | 21 | int:KCNA3 |
| Interaction | STARD13 interactions | 2.76e-05 | 68 | 175 | 6 | int:STARD13 | |
| Interaction | CDC42 interactions | RALGAPA1 EHBP1 MAGI1 ATP6V1A MYH10 HYOU1 ANK3 DOCK11 DSP ARHGAP26 NTPCR LRRK2 RFX6 MSH3 PHAX RCC2 DHX9 MFAP3 MDN1 FAF2 ANLN WASF2 KCTD3 MKI67 KIF14 EPB41L1 STOM | 2.89e-05 | 1323 | 175 | 27 | int:CDC42 |
| Interaction | PPP1R9B interactions | ATP6V1A MYH10 MYH11 ANK3 DSP CKAP5 RFX6 DCX DHX9 ANLN CCT8 KIF14 CTNNA2 DCLK1 EPB41L1 GOT2 RPL13 | 3.38e-05 | 626 | 175 | 17 | int:PPP1R9B |
| Interaction | SIRT6 interactions | EP400 DOCK11 DSP KPNA6 PRC1 PRPF8 SKP2 DDX27 GTF3C4 DHX9 PRPF3 MKI67 CCT8 GFPT2 MAPK3 DHX29 SYMPK | 3.52e-05 | 628 | 175 | 17 | int:SIRT6 |
| Interaction | CNTNAP4 interactions | 3.56e-05 | 22 | 175 | 4 | int:CNTNAP4 | |
| Interaction | ACTC1 interactions | DHX16 MYH10 EP400 FARSB KPNA6 PRC1 PHAX RCC2 GTF3C4 ISY1 LUZP1 MFAP1 PRPF3 ANLN WASF2 MKI67 CCT8 KIF14 | 3.59e-05 | 694 | 175 | 18 | int:ACTC1 |
| Interaction | MYH14 interactions | 4.19e-05 | 189 | 175 | 9 | int:MYH14 | |
| Interaction | KIF20A interactions | DHX16 RALGAPA1 MYH10 MYH11 DSP HMGCR PRC1 PRPF8 DDX27 PPL LUZP1 DHX9 MFAP1 SAMD9L FAF2 ANLN MKI67 KIF14 HERC1 STX17 TRPV5 STOM RPL13 | 4.25e-05 | 1052 | 175 | 23 | int:KIF20A |
| Interaction | CBX3 interactions | DHX16 BRIP1 ZNF354A EP400 JADE3 LRRK2 KPNA6 BTAF1 PRC1 GTF3C4 MFAP1 PRR14 PRPF3 ANLN MKI67 KIF14 DNMT1 | 5.00e-05 | 646 | 175 | 17 | int:CBX3 |
| Interaction | PPIB interactions | HYOU1 ANK3 LRRK2 PRC1 PRPF8 DHX9 ANLN MKI67 KIF14 TXNDC16 OS9 GOT2 | 5.06e-05 | 345 | 175 | 12 | int:PPIB |
| Interaction | PFKFB1 interactions | 7.07e-05 | 26 | 175 | 4 | int:PFKFB1 | |
| Interaction | MTPN interactions | 7.33e-05 | 158 | 175 | 8 | int:MTPN | |
| Interaction | ZC3H18 interactions | MYH10 DSP FARSB SRP68 PRC1 PRPF8 DDX27 RCC2 ISY1 DHX9 NGDN DNAJA3 MFAP1 PRPF3 ANLN RBM15B CCT8 KIF14 EPB41L1 RPL13 | 7.88e-05 | 877 | 175 | 20 | int:ZC3H18 |
| Interaction | WDR3 interactions | 8.01e-05 | 160 | 175 | 8 | int:WDR3 | |
| Interaction | DDA1 interactions | ANK3 DSP FARSB MSH3 PHAX PRPF8 RCC2 GTF3C4 ISY1 NGDN PCIF1 KIF14 | 9.36e-05 | 368 | 175 | 12 | int:DDA1 |
| Interaction | THOC1 interactions | 9.45e-05 | 210 | 175 | 9 | int:THOC1 | |
| Interaction | EZR interactions | EHBP1 ANK3 ECD L1CAM FARSB SRP68 PRPF8 GTF3C4 PPL LUZP1 ANLN WASF2 KIF14 EPB41L1 VCAM1 | 1.01e-04 | 553 | 175 | 15 | int:EZR |
| Interaction | PABPC1L2A interactions | 1.01e-04 | 11 | 175 | 3 | int:PABPC1L2A | |
| Interaction | PHB1 interactions | ATP6V1A MYH10 MAGED1 HYOU1 NTPCR FARSB SMG5 PRC1 PHAX PRPF8 SKP2 GTF3C4 DHX9 DNAJA3 MDN1 PRPF3 ANLN CCT8 KIF14 HSD17B11 VCAM1 STOM RPL13 | 1.14e-04 | 1123 | 175 | 23 | int:PHB1 |
| Interaction | SLC6A4 interactions | RALGAPA1 MAGI1 ACSL6 MAGED1 ARHGAP26 SRP68 ADGRV1 LUZP1 DNAJA3 NWD2 KCTD3 MAPK3 EPB41L1 | 1.20e-04 | 437 | 175 | 13 | int:SLC6A4 |
| Interaction | TOP1 interactions | DHX16 EP400 CKAP5 RCVRN PRC1 PRPF8 GTF3C4 ISY1 DHX9 MFAP1 PRPF3 ANLN MKI67 KIF14 DHX29 VCAM1 SYMPK | 1.24e-04 | 696 | 175 | 17 | int:TOP1 |
| Interaction | CIT interactions | DHX16 MAGI1 MYH10 MYH11 EP400 DSP LRRK2 CKAP5 SRP68 ADGRV1 PRC1 PRPF8 GTF3C4 LUZP1 DHX9 DNAJA3 MFAP1 FAF2 PRPF3 ANLN MKI67 CCT8 KIF14 HERC1 TRPV5 RPL13 SYMPK | 1.36e-04 | 1450 | 175 | 27 | int:CIT |
| Interaction | RIPK4 interactions | MAGED1 HYOU1 ANK3 ECD NTPCR SMG5 RCC2 DNAJA3 MDN1 FAF2 CCT8 GOT2 RPL13 | 1.47e-04 | 446 | 175 | 13 | int:RIPK4 |
| Interaction | CDC5L interactions | DHX16 MPP2 DSP CKAP5 SRP68 BTAF1 PRC1 PRPF8 ISY1 DHX9 MDN1 PRPF3 ANLN DZIP3 CCT8 KIF14 DIXDC1 RPL13 SYMPK | 1.68e-04 | 855 | 175 | 19 | int:CDC5L |
| Interaction | XRCC6 interactions | DHX16 MYH10 HYOU1 EP400 FARSB PRC1 PHAX PRPF8 SKP2 GTF3C4 DHX9 MFAP1 PRPF3 ANLN MKI67 CCT8 SLX4IP KIF14 VCAM1 DNMT1 | 1.68e-04 | 928 | 175 | 20 | int:XRCC6 |
| Interaction | PTEN interactions | MYH10 ACACB DSP ARHGAP26 FARSB PRPF8 RCC2 PPL LUZP1 DHX9 DNAJA3 FSIP2 MDN1 MKI67 CCT8 KIF14 TNKS2 EPB41L1 GOT2 RPL13 | 1.71e-04 | 929 | 175 | 20 | int:PTEN |
| Interaction | HDAC6 interactions | MYH10 MYH11 BRIP1 ZNF354A EP400 DSP LRRK2 SRP68 MSH3 RRAS PRPF8 CCDC141 RCC2 DHX9 CCT8 KIF14 MAPK3 GOT2 STOM RPL13 | 1.71e-04 | 929 | 175 | 20 | int:HDAC6 |
| Interaction | ATG16L1 interactions | MAGED1 ACACB ANK3 ECD CKAP5 FARSB CCDC168 PRC1 FHIP2A ISY1 DHX9 DNAJA3 MAP1LC3C ANLN WASF2 RBM15B CCT8 KIF14 DIXDC1 MAPK3 HERC1 TNKS2 DNMT1 | 1.85e-04 | 1161 | 175 | 23 | int:ATG16L1 |
| Interaction | RPS3A interactions | MYH10 SRP68 PRC1 PHAX PRPF8 DDX27 DHX9 NGDN PRPF3 ANLN KIF14 DHX29 NOS2 VCAM1 CREB3 RPL13 | 1.97e-04 | 655 | 175 | 16 | int:RPS3A |
| Interaction | NCKIPSD interactions | 1.97e-04 | 137 | 175 | 7 | int:NCKIPSD | |
| Interaction | CD2BP2 interactions | 2.00e-04 | 232 | 175 | 9 | int:CD2BP2 | |
| Interaction | RPL13A interactions | DOCK11 SRP68 PRC1 PRPF8 DDX27 DHX9 NGDN PRPF3 ANLN MKI67 KIF14 DHX29 VCAM1 STOM RPL13 | 2.08e-04 | 591 | 175 | 15 | int:RPL13A |
| Interaction | SUMO2 interactions | EP400 LRRK2 CKAP5 FARSB SRP68 MSH3 PRC1 PRPF8 GTF3C4 MDN1 ANLN MKI67 SLX4IP DNMT1 SYMPK | 2.08e-04 | 591 | 175 | 15 | int:SUMO2 |
| Interaction | H1-5 interactions | EHBP1 HYOU1 DSP CCDC168 PRC1 DDX27 MFAP1 ANLN SLX4IP KIF14 VCAM1 RPL13 SOS1 | 2.12e-04 | 463 | 175 | 13 | int:H1-5 |
| Interaction | PSMD14 interactions | MAGI1 BRIP1 DSP PRPF8 DHX9 VPS13D FAF2 PSME4 CARD9 CCT8 HERC1 NOS2 GOT2 SOS1 | 2.14e-04 | 527 | 175 | 14 | int:PSMD14 |
| Interaction | METAP2 interactions | 2.25e-04 | 289 | 175 | 10 | int:METAP2 | |
| Interaction | COPS5 interactions | EHBP1 DSP SRP68 KPNA6 PHAX SKP2 PTGS2 RCC2 DHX9 TXNRD1 PSME4 KCTD3 CCT8 CARD11 PLCG1 MAPK3 DHX29 EPB41L1 GOT2 STOM CREB3 RPL13 | 2.32e-04 | 1102 | 175 | 22 | int:COPS5 |
| Interaction | YWHAH interactions | RALGAPA1 EHBP1 KIF21B MAGI1 MYH11 DOCK11 DSP LRRK2 CKAP5 ENKD1 LUZP1 VPS13D KANK1 ANLN WASF2 RBM15B KIF14 HERC1 DCLK1 EPB41L1 DNMT1 DOP1B | 2.32e-04 | 1102 | 175 | 22 | int:YWHAH |
| Interaction | CWC22 interactions | 2.35e-04 | 141 | 175 | 7 | int:CWC22 | |
| Interaction | CAVIN1 interactions | 2.45e-04 | 292 | 175 | 10 | int:CAVIN1 | |
| Interaction | MYL9 interactions | 2.91e-04 | 67 | 175 | 5 | int:MYL9 | |
| Interaction | PINK1 interactions | DHX16 ATP6V1A MYH10 MAGED1 HYOU1 DSP ECD FARSB SRP68 PRPF8 PPL LUZP1 DHX9 KCTD3 CCT8 RPL13 | 2.94e-04 | 679 | 175 | 16 | int:PINK1 |
| Interaction | AATK interactions | 3.01e-04 | 194 | 175 | 8 | int:AATK | |
| Interaction | PPIL1 interactions | 3.03e-04 | 147 | 175 | 7 | int:PPIL1 | |
| Interaction | NUPR1 interactions | KIF21B ATP6V1A MYH10 KPNA6 MSH3 PRC1 PRPF8 F5 RCC2 LUZP1 DHX9 MFAP1 PRPF3 ANLN MKI67 KIF14 | 3.14e-04 | 683 | 175 | 16 | int:NUPR1 |
| Interaction | WDR83 interactions | 3.23e-04 | 196 | 175 | 8 | int:WDR83 | |
| Interaction | MECP2 interactions | DHX16 MYH10 ZNF354A EP400 DSP SRP68 PRC1 PRPF8 DCX RCC2 ISY1 DHX9 DNAJA3 MFAP1 ZNF800 NWD2 PRPF3 ANLN KCTD3 MKI67 RBM15B RPL13 DNMT1 SYMPK | 3.26e-04 | 1287 | 175 | 24 | int:MECP2 |
| Cytoband | 6p24 | 9.23e-05 | 4 | 181 | 2 | 6p24 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.22e-05 | 161 | 114 | 7 | 593 | |
| GeneFamily | DEAH-box helicases | 1.29e-04 | 16 | 114 | 3 | 500 | |
| GeneFamily | Dyneins, axonemal | 1.56e-04 | 17 | 114 | 3 | 536 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 2.35e-04 | 4 | 114 | 2 | 1244 | |
| GeneFamily | UNC13 homologs | 2.35e-04 | 4 | 114 | 2 | 836 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 5.71e-04 | 26 | 114 | 3 | 904 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.08e-03 | 8 | 114 | 2 | 939 | |
| GeneFamily | CUT class homeoboxes and pseudogenes | 1.38e-03 | 9 | 114 | 2 | 527 | |
| GeneFamily | Doublecortin superfamily | 1.72e-03 | 10 | 114 | 2 | 1369 | |
| GeneFamily | Fibronectin type III domain containing | 3.45e-03 | 160 | 114 | 5 | 555 | |
| GeneFamily | Myosin heavy chains | 3.92e-03 | 15 | 114 | 2 | 1098 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 4.14e-06 | 180 | 178 | 9 | M8239 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | MPP2 EHBP1 ACSL6 BRIP1 MAGED1 CKAP5 MSH3 PRC1 RCC2 DHX9 SLC9A5 ANLN MKI67 RBM15B KIF14 RAB39B DNMT1 | 4.28e-06 | 680 | 178 | 17 | MM456 |
| Coexpression | ACEVEDO_LIVER_CANCER_UP | DHX16 ATP6V1A HYOU1 NTPCR BCAT2 BTAF1 PRC1 PHAX FHIP2A DDX27 PPL TXNRD1 MFAP1 PRPF3 ZPR1 KCTD3 PLCG1 HSD17B11 DHX29 DNMT1 | 1.09e-05 | 972 | 178 | 20 | M15709 |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP | 2.85e-05 | 176 | 178 | 8 | M2981 | |
| Coexpression | GSE21927_UNTREATED_VS_GMCSF_IL6_TREATED_BONE_MARROW_DN | 4.06e-05 | 185 | 178 | 8 | M7567 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_DN | 5.68e-05 | 194 | 178 | 8 | M8864 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | KIF21B GPR155 ACSL6 ZNF354A ANK3 L1CAM LRRK2 CCDC141 DCX DSCAML1 FSIP2 LMOD3 MDN1 PIK3CD CTNNA2 HERC1 HYDIN DCLK1 EPB41L1 DOP1B | 6.71e-05 | 1106 | 178 | 20 | M39071 |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | 6.80e-05 | 199 | 178 | 8 | M9443 | |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_DN | 6.80e-05 | 199 | 178 | 8 | M8031 | |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_DN | 7.04e-05 | 200 | 178 | 8 | M9311 | |
| Coexpression | GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP | 7.04e-05 | 200 | 178 | 8 | M8653 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | DHX16 KIF21B RMND5A ZNF354A EP400 ECD OBSCN ZNF267 KPNA6 BTAF1 ONECUT1 DDX27 DHX9 NGDN MFAP3 PIK3CD MKI67 ALPK3 CCT8 PLCG1 NOS2 MX2 DNMT1 | 7.53e-05 | 1394 | 178 | 23 | M9585 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | RALGAPA1 KIF21B GPR155 THEMIS EP400 DOCK11 KPNA6 BTAF1 PRPF8 FHIP2A LUZP1 DHX9 ZNF800 SAMD9L GIMAP8 PIK3CD DZIP3 CARD11 PLCG1 HERC1 STOM RPL13 DNMT1 SOS1 | 7.69e-05 | 1492 | 178 | 24 | M40023 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | GPR155 ABCC4 CUX2 BRIP1 DSP L1CAM ANO1 PRC1 CCDC141 DCX GALNT18 PTGS2 TARS3 SAMD9L KIF14 B4GALNT3 CADPS2 CDH11 VCAM1 STOM | 8.27e-06 | 783 | 176 | 20 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | MAGI1 ABCC4 ARHGAP26 LRRK2 GRM8 DSCAML1 GALNT18 PPL HYDIN EPB41L1 | 7.51e-09 | 194 | 181 | 10 | e577d9e88390b36b5a09b97fe1026089892275a3 |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 7.75e-08 | 187 | 181 | 9 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.49e-08 | 189 | 181 | 9 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.88e-08 | 190 | 181 | 9 | b99271d139c8d01e20feb95d99f79c9b2756b4cb | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.29e-08 | 191 | 181 | 9 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.29e-08 | 191 | 181 | 9 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | UNC13B MAGI1 ANK3 LRRK2 ADGRV1 CCDC141 KANK1 B4GALNT3 CADPS2 | 9.29e-08 | 191 | 181 | 9 | e432c6e1ae82dddf84314ce73d2b7a991630d905 |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 9.71e-08 | 192 | 181 | 9 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.71e-08 | 192 | 181 | 9 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.06e-07 | 194 | 181 | 9 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.32e-07 | 199 | 181 | 9 | b10698aee2e6c17bc559eb4f723024141f914b90 | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.32e-07 | 199 | 181 | 9 | 38f1f612b29feb868322999ceeda78e52447ec4f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_IT_L5/L6_Car3_THEMIS-Exc_L5-6_THEMIS_THTPA|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.00e-07 | 178 | 181 | 8 | e4e11e4940c911c17806200c25096928153c684d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.00e-07 | 178 | 181 | 8 | c20f050344a2e120e685e2a7fe36c6dfc1dc37b6 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 7.61e-07 | 180 | 181 | 8 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.62e-07 | 183 | 181 | 8 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 9.36e-07 | 185 | 181 | 8 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.36e-07 | 185 | 181 | 8 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.74e-07 | 186 | 181 | 8 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.74e-07 | 186 | 181 | 8 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-06 | 188 | 181 | 8 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.19e-06 | 191 | 181 | 8 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 1.24e-06 | 192 | 181 | 8 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 1.24e-06 | 192 | 181 | 8 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.24e-06 | 192 | 181 | 8 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.29e-06 | 193 | 181 | 8 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.29e-06 | 193 | 181 | 8 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 1.29e-06 | 193 | 181 | 8 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.34e-06 | 194 | 181 | 8 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 194 | 181 | 8 | effd38e51062b225ecabc7e1c50154e65495d559 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.39e-06 | 195 | 181 | 8 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.39e-06 | 195 | 181 | 8 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.39e-06 | 195 | 181 | 8 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.44e-06 | 196 | 181 | 8 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.50e-06 | 197 | 181 | 8 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.50e-06 | 197 | 181 | 8 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-06 | 198 | 181 | 8 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.56e-06 | 198 | 181 | 8 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | Endothelial-Endothelial-H_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 1.58e-06 | 138 | 181 | 7 | a1f41a5a9da40adcc343722baef78c603599c3f0 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-06 | 199 | 181 | 8 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.68e-06 | 200 | 181 | 8 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.68e-06 | 200 | 181 | 8 | 13ec8afea86e4a10599c924871ba4e325b0a8013 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 3.72e-06 | 157 | 181 | 7 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue | 3.72e-06 | 157 | 181 | 7 | d4da4057917dda066da0f2aac2621fdaf1fb943b | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-06 | 160 | 181 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.22e-06 | 160 | 181 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.16e-06 | 165 | 181 | 7 | dbe231d00843cae917efd1abea6079ace3b45cdf | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.16e-06 | 165 | 181 | 7 | 9ccce713d4122054bf4bef4a7126d90cf9141b84 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.37e-06 | 166 | 181 | 7 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.59e-06 | 167 | 181 | 7 | 754e6412d3b9cc0b126e59593df2f5956b4712ef | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.04e-06 | 169 | 181 | 7 | 563c267edaade0e5df192ad953801ef9768d4270 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-06 | 169 | 181 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.53e-06 | 171 | 181 | 7 | e59afa0a773dca3b9c208d17510ea55703b42598 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.32e-06 | 174 | 181 | 7 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.32e-06 | 174 | 181 | 7 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.18e-06 | 177 | 181 | 7 | f902600c639087664316b3cf30cab243bc3d1c5c | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.18e-06 | 177 | 181 | 7 | c9b02a2e1ff2aa18c37e88a53b06a5b696a442ae | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.80e-06 | 179 | 181 | 7 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.13e-06 | 180 | 181 | 7 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.46e-06 | 181 | 181 | 7 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.02e-05 | 183 | 181 | 7 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 184 | 181 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 184 | 181 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters | 1.05e-05 | 184 | 181 | 7 | 2e0c9a2c40c892a2d435eafb31f1f838de9baf15 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 1.05e-05 | 184 | 181 | 7 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 184 | 181 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 184 | 181 | 7 | da06ff24ee2b2cf4715fdfce43030b2da9e0aaf8 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 1.09e-05 | 185 | 181 | 7 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.13e-05 | 186 | 181 | 7 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | IPF-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.13e-05 | 186 | 181 | 7 | 6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.13e-05 | 186 | 181 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.13e-05 | 186 | 181 | 7 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-05 | 187 | 181 | 7 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | Fibroblast-E_(Early_Fibroblastic_progenitor)|World / shred on cell class and cell subclass (v4) | 1.21e-05 | 188 | 181 | 7 | be3db9768364568f44e32ae6b3bf99e49b0978bb | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 188 | 181 | 7 | 40ce7125fca6f6b6b5cc1637c87d43c29b08f4f1 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 188 | 181 | 7 | ba7f7ce034c0f42742bf2461f68f8d343ee593a5 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 1.21e-05 | 188 | 181 | 7 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | facs-Heart-LA/RA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 189 | 181 | 7 | a08b2d0fa35ffa510050ecffdc68e1b79bbe1632 | |
| ToppCell | facs-Heart-LA/RA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 189 | 181 | 7 | efa913d9c16fc32166b484d92b6449e8a0c59e03 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 1.25e-05 | 189 | 181 | 7 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 189 | 181 | 7 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.30e-05 | 190 | 181 | 7 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 191 | 181 | 7 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 1.34e-05 | 191 | 181 | 7 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-05 | 191 | 181 | 7 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.34e-05 | 191 | 181 | 7 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 1.34e-05 | 191 | 181 | 7 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 191 | 181 | 7 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 192 | 181 | 7 | 96f23d6e8604d1cb24910d3118d8171b57c93e14 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 192 | 181 | 7 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | NS-moderate-d_0-4-Lymphoid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.39e-05 | 192 | 181 | 7 | 905217dcfc843d3469e9e71bd33707863b14cc82 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-05 | 193 | 181 | 7 | a332dfdcc48c405020014e644aa4d14fda98cc86 | |
| ToppCell | Thalamus-Macroglia-OLIGODENDROCYTE|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.47e-05 | 129 | 181 | 6 | b3cb0c10659d1216b8f7de3aa1f9aac101cb65dd | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.48e-05 | 194 | 181 | 7 | c197e4acbff42a9f0410b6801c2bfcf6160aefc1 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.53e-05 | 195 | 181 | 7 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 195 | 181 | 7 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.53e-05 | 195 | 181 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 1.59e-05 | 196 | 181 | 7 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 1.59e-05 | 196 | 181 | 7 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 196 | 181 | 7 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 | |
| Drug | pioglitazone | DSP SLC2A7 GPT BCAT2 SKP2 PTGS2 STAR MLYCD PIK3CD CTNNA2 GFPT2 NOS2 VCAM1 GOT2 | 3.04e-07 | 326 | 178 | 14 | CID000004829 |
| Drug | sodium bisulfide | 6.46e-07 | 40 | 178 | 6 | ctd:C025451 | |
| Drug | aminoguanidine hydrochloride | 2.44e-06 | 13 | 178 | 4 | CID000016017 | |
| Drug | quinocetone | ACSL6 ARHGAP26 LRRK2 HMGCR ADGRV1 GRM8 TXNRD1 TXNDC16 NOS2 CDH11 DCLK1 | 4.31e-06 | 248 | 178 | 11 | ctd:C502851 |
| Drug | capsazepine | 4.33e-06 | 84 | 178 | 7 | CID002733484 | |
| Drug | sorbinil | 4.61e-06 | 15 | 178 | 4 | ctd:C026411 | |
| Drug | 4-(nitroxy)butanoic acid 4-acetylaminophenyl ester | 4.64e-06 | 5 | 178 | 3 | ctd:C478738 | |
| Drug | FK-3 | 4.64e-06 | 5 | 178 | 3 | CID000127417 | |
| Drug | quercetin pentaacetate | 4.64e-06 | 5 | 178 | 3 | ctd:C435940 | |
| Drug | 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione | 7.40e-06 | 60 | 178 | 6 | ctd:C060229 | |
| Drug | 7,8-diacetoxy-4-methylcoumarin | 7.94e-06 | 17 | 178 | 4 | ctd:C114369 | |
| Drug | oleuropein | 7.94e-06 | 17 | 178 | 4 | ctd:C002769 | |
| Drug | cupric chloride | RALGAPA1 GPX8 FARSB BCAT2 PRPF8 PTGS2 TXNRD1 CKM IGSF22 ZPR1 TRPV6 MAPK3 USH2A NOS1 NOS2 TRPV5 DOP1B | 8.47e-06 | 623 | 178 | 17 | ctd:C029892 |
| Drug | zingerone | 1.28e-05 | 19 | 178 | 4 | ctd:C013738 | |
| Drug | fucoxanthin | 1.59e-05 | 20 | 178 | 4 | ctd:C025164 | |
| Drug | nectandrin-B | 1.59e-05 | 20 | 178 | 4 | ctd:C524653 | |
| Drug | sulphoraphene | 1.61e-05 | 7 | 178 | 3 | ctd:C473643 | |
| Drug | vitisin A | 1.61e-05 | 7 | 178 | 3 | ctd:C412469 | |
| Drug | Ternatin Heptapeptide | 1.61e-05 | 7 | 178 | 3 | CID000192406 | |
| Drug | CAS 93957-55-2 | 1.72e-05 | 187 | 178 | 9 | CID000003403 | |
| Drug | Dactinomycin | ACSL6 RRAS PTGS2 TXNRD1 NGF TRPV6 MAPK3 NOS2 VCAM1 STOM SOS1 | 1.88e-05 | 290 | 178 | 11 | ctd:D003609 |
| Drug | Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin | 1.95e-05 | 21 | 178 | 4 | ctd:C502230 | |
| Drug | Lysophosphatidylcholines | 2.37e-05 | 22 | 178 | 4 | ctd:D008244 | |
| Drug | Fructose | 2.52e-05 | 246 | 178 | 10 | ctd:D005632 | |
| Drug | pelargonidin | 2.56e-05 | 8 | 178 | 3 | ctd:C066957 | |
| Drug | NSC-659366 | 2.56e-05 | 8 | 178 | 3 | CID000377762 | |
| Drug | phlorofucofuroeckol A | 2.56e-05 | 8 | 178 | 3 | ctd:C064093 | |
| Drug | (5-formylfuran-2-yl)methyl 4-hydroxy-2-methylenebutanoate | 2.56e-05 | 8 | 178 | 3 | ctd:C575152 | |
| Drug | Phenformin hydrochloride [834-28-6]; Up 200; 16.6uM; HL60; HT_HG-U133A | 2.59e-05 | 197 | 178 | 9 | 2350_UP | |
| Drug | myricetin | 2.70e-05 | 75 | 178 | 6 | ctd:C040015 | |
| Drug | nitroprusside | 2.72e-05 | 111 | 178 | 7 | CID011947681 | |
| Drug | Mevalonic Acid | 2.72e-05 | 111 | 178 | 7 | ctd:D008798 | |
| Drug | Nifedipine | 2.88e-05 | 112 | 178 | 7 | ctd:D009543 | |
| Drug | Fenofibrate | ACSL6 ABCC4 ACACB EP400 NTPCR BCAT2 HMGCR PTGS2 MLYCD TXNRD1 DNAJA3 USP38 MKI67 NOS2 VCAM1 GOT2 | 3.35e-05 | 624 | 178 | 16 | ctd:D011345 |
| Drug | chrysin | 3.42e-05 | 115 | 178 | 7 | ctd:C043561 | |
| Drug | 3alpha, 7beta-dihydroxy-5beta-cholan-24-oic acid | 3.68e-05 | 206 | 178 | 9 | CID000005645 | |
| Drug | Diketopiperazines | 3.81e-05 | 9 | 178 | 3 | ctd:D054659 | |
| Drug | 17-hydroxyjolkinolide B | 3.81e-05 | 9 | 178 | 3 | ctd:C057916 | |
| Drug | bifendate | 3.81e-05 | 9 | 178 | 3 | ctd:C465548 | |
| Drug | neohesperidin dihydrochalcone | 3.81e-05 | 9 | 178 | 3 | ctd:C013613 | |
| Drug | baohuoside I | 4.02e-05 | 25 | 178 | 4 | ctd:C060988 | |
| Drug | triflusal | 4.02e-05 | 25 | 178 | 4 | CID000009458 | |
| Drug | potassium | ANK3 RCVRN HMGCR GRM8 F5 MLYCD SLC9A5 CLCA2 PIK3CD NGF GPR156 OS9 TRPV6 CARD11 PLCG1 MAPK3 NOS1 NOS2 TRPV5 STOM SOS1 | 4.27e-05 | 1008 | 178 | 21 | CID000000813 |
| Drug | alfacalcidol | 4.72e-05 | 26 | 178 | 4 | ctd:C008088 | |
| Drug | Melitten | 4.81e-05 | 83 | 178 | 6 | ctd:D008555 | |
| Drug | Losartan | 4.82e-05 | 165 | 178 | 8 | ctd:D019808 | |
| Drug | Lindane | RALGAPA1 KIF21B ABCC4 ZNF354A GPT ONECUT1 F5 DDX27 PTGS2 STAR MAPK3 NOS2 RPL13 | 4.86e-05 | 443 | 178 | 13 | ctd:D001556 |
| Drug | FK3311 | 5.42e-05 | 10 | 178 | 3 | CID000164009 | |
| Drug | 3,5-bis(trifluoromethyl)pyrazole | 5.42e-05 | 10 | 178 | 3 | CID000518991 | |
| Drug | AC1N6UEL | 5.42e-05 | 10 | 178 | 3 | CID004221373 | |
| Drug | irisolidone | 5.42e-05 | 10 | 178 | 3 | CID005281781 | |
| Drug | cyanidin 3-O-glucoside | 5.51e-05 | 27 | 178 | 4 | ctd:C114438 | |
| Drug | 8,11,14-Eicosatrienoic Acid | 6.08e-05 | 2 | 178 | 2 | ctd:D015126 | |
| Drug | AC1L57TJ | 6.08e-05 | 2 | 178 | 2 | CID000171606 | |
| Drug | N-(3-chlorophenyl)-2-(4-((2,4-dioxothiazolidin-5-ylidene)methyl)phenoxy)acetamide | 6.08e-05 | 2 | 178 | 2 | ctd:C582844 | |
| Drug | N-Omega-Propyl-L-Arginine | 6.08e-05 | 2 | 178 | 2 | DB02644 | |
| Drug | Mycoplasma arthritidis mitogen | 6.08e-05 | 2 | 178 | 2 | ctd:C052996 | |
| Drug | diphenylmethyl selenocyanate | 6.08e-05 | 2 | 178 | 2 | ctd:C495419 | |
| Drug | N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine | 6.08e-05 | 2 | 178 | 2 | DB03449 | |
| Drug | 4-((2'-O-acetylrhamnosyloxy)benzyl)isothiocyanate | 6.08e-05 | 2 | 178 | 2 | ctd:C568824 | |
| Drug | eugenosedin-A | 6.08e-05 | 2 | 178 | 2 | ctd:C496985 | |
| Drug | zinc protoporphyrin | 6.13e-05 | 126 | 178 | 7 | CID000027287 | |
| Drug | diallyl disulfide | 7.00e-05 | 55 | 178 | 5 | ctd:C028009 | |
| Drug | troglitazone | MYH11 SLC2A7 GPT BCAT2 SKP2 PTGS2 STAR SIL1 PIK3CD GFPT2 MAPK3 NOS1 NOS2 GOT2 | 7.11e-05 | 526 | 178 | 14 | CID000005591 |
| Drug | tamibarotene | ATP6V1A MYH10 MYH11 RMND5A ZNF267 SKP2 MFAP3 MDN1 PIK3CD MAPK3 NOS2 MX2 CCDC93 CREB3 SYMPK | 7.32e-05 | 596 | 178 | 15 | ctd:C061133 |
| Drug | sodium sulfite | 7.40e-05 | 11 | 178 | 3 | ctd:C025026 | |
| Drug | quercetin 3'-sulfate | 7.40e-05 | 11 | 178 | 3 | ctd:C531389 | |
| Drug | patchouli alcohol | 7.40e-05 | 11 | 178 | 3 | ctd:C052983 | |
| Drug | AC1NURR2 | 7.40e-05 | 11 | 178 | 3 | CID005490351 | |
| Drug | N-(4-O-glycerol-3-methoxybenzyl)nonivamide | 7.40e-05 | 11 | 178 | 3 | ctd:C080418 | |
| Drug | Tetracycline | ACSL6 ABCC4 ACACB FARSB HMGCR MSH3 ONECUT1 PTGS2 TXNRD1 PIK3CD TXNDC16 TRPV6 PLCG1 MAPK3 DHX29 GDF11 | 7.50e-05 | 668 | 178 | 16 | ctd:D013752 |
| Drug | Metformin | ACACB EP400 GPT NTPCR BCAT2 HMGCR PRC1 STAR TXNRD1 MAPK3 NOS1 NOS2 | 7.74e-05 | 400 | 178 | 12 | ctd:D008687 |
| Drug | ebselen | 7.84e-05 | 131 | 178 | 7 | CID000003194 | |
| Drug | bisindolylmaleimide I | 7.84e-05 | 131 | 178 | 7 | ctd:C070515 | |
| Drug | Amiodarone | DHX16 ACSL6 ATP6V1A ABCC4 MYH11 ACACB GPT FARSB HMGCR MSH3 PTGS2 MLYCD ERMN TXNRD1 CARD9 SLX4IP TXNDC16 TRPV6 PLCG1 RAB39B CADPS2 HSD17B11 GDF11 VCAM1 GOT2 RPL13 | 7.85e-05 | 1469 | 178 | 26 | ctd:D000638 |
| Drug | 17alpha-estradiol | ABCC4 HMGCR RRAS PRC1 SKP2 PTGS2 STAR SIL1 DHX9 CKM PSME4 CLCA2 PIK3CD NGF CARD11 PLCG1 GFPT2 MAPK3 HSD17B11 NOS1 NOS2 CDH11 VCAM1 DNMT1 | 8.28e-05 | 1303 | 178 | 24 | CID000000450 |
| Drug | pheophytin | 8.41e-05 | 284 | 178 | 10 | CID000000250 | |
| Drug | cnicin | 8.58e-05 | 92 | 178 | 6 | CID000091176 | |
| Drug | Cyclophosphamide | KIF21B MYH10 MAGED1 HYOU1 GPT MSH3 PTGS2 TXNRD1 NGF MAPK3 NOS2 VCAM1 MX2 STOM DNMT1 | 8.97e-05 | 607 | 178 | 15 | ctd:D003520 |
| Drug | morin | 9.05e-05 | 58 | 178 | 5 | ctd:C008548 | |
| Drug | beta-Naphthoflavone | ABCC4 MYH10 ZNF354A ACACB GPT KPNA6 HMGCR PTGS2 STAR TXNRD1 KANK1 MAPK3 NOS2 GDF11 TRPV5 CDH11 DCLK1 VCAM1 | 9.12e-05 | 828 | 178 | 18 | ctd:D019324 |
| Drug | Thiourea | 9.64e-05 | 31 | 178 | 4 | ctd:D013890 | |
| Drug | 1-hydroxy-2-naphthoic acid | 9.81e-05 | 12 | 178 | 3 | ctd:C050175 | |
| Drug | fraxinellone | 9.81e-05 | 12 | 178 | 3 | ctd:C075391 | |
| Drug | AC1L4N48 | 9.81e-05 | 12 | 178 | 3 | CID000160143 | |
| Drug | beta-ionone | 9.81e-05 | 12 | 178 | 3 | ctd:C008157 | |
| Drug | Atorvastatin Calcium | 1.12e-04 | 186 | 178 | 8 | ctd:D000069059 | |
| Drug | allyl sulfide | 1.22e-04 | 98 | 178 | 6 | ctd:C038491 | |
| Drug | puerarin | 1.22e-04 | 98 | 178 | 6 | ctd:C033607 | |
| Drug | allyl alcohol | 1.24e-04 | 33 | 178 | 4 | ctd:C006463 | |
| Drug | Oligomycins | 1.24e-04 | 33 | 178 | 4 | ctd:D009840 | |
| Drug | 27-hydroxycholesterol | 1.25e-04 | 62 | 178 | 5 | ctd:C076996 | |
| Drug | Russian VX | 1.25e-04 | 62 | 178 | 5 | CID000178033 | |
| Drug | hexahydrocurcumin | 1.27e-04 | 13 | 178 | 3 | CID005318039 | |
| Drug | niuhuang | 1.27e-04 | 13 | 178 | 3 | ctd:C570000 | |
| Drug | dabrafenib | 1.27e-04 | 13 | 178 | 3 | ctd:C561627 | |
| Drug | 8-oxo-7-hydrodeoxyguanosine | 1.27e-04 | 13 | 178 | 3 | ctd:C067134 | |
| Drug | AC1L1WQ4 | 1.27e-04 | 13 | 178 | 3 | CID000011152 | |
| Drug | tetrahydrocurcumin | 1.27e-04 | 13 | 178 | 3 | ctd:C096277 | |
| Drug | Econazole nitrate [24169-02-6]; Down 200; 9uM; PC3; HT_HG-U133A | 1.29e-04 | 190 | 178 | 8 | 7305_DN | |
| Disease | interstitial cystitis (is_marker_for) | 1.93e-06 | 5 | 172 | 3 | DOID:13949 (is_marker_for) | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 2.54e-06 | 147 | 172 | 8 | DOID:9352 (biomarker_via_orthology) | |
| Disease | vitamin K measurement | 1.59e-05 | 9 | 172 | 3 | EFO_0004618 | |
| Disease | Grand Mal Status Epilepticus | 4.58e-05 | 67 | 172 | 5 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 4.58e-05 | 67 | 172 | 5 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 4.58e-05 | 67 | 172 | 5 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 4.58e-05 | 67 | 172 | 5 | C0751523 | |
| Disease | Petit mal status | 4.58e-05 | 67 | 172 | 5 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 4.58e-05 | 67 | 172 | 5 | C0393734 | |
| Disease | Status Epilepticus | 4.92e-05 | 68 | 172 | 5 | C0038220 | |
| Disease | epilepsy (implicated_via_orthology) | 5.02e-05 | 163 | 172 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | Polyposis, Adenomatous Intestinal | 1.03e-04 | 16 | 172 | 3 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 1.03e-04 | 16 | 172 | 3 | C2713443 | |
| Disease | hypothyroidism (biomarker_via_orthology) | 1.07e-04 | 80 | 172 | 5 | DOID:1459 (biomarker_via_orthology) | |
| Disease | diabetic neuropathy (biomarker_via_orthology) | 1.25e-04 | 17 | 172 | 3 | DOID:9743 (biomarker_via_orthology) | |
| Disease | Adenomatous Polyposis Coli | 1.25e-04 | 17 | 172 | 3 | C0032580 | |
| Disease | Allodynia | 1.35e-04 | 84 | 172 | 5 | C0458247 | |
| Disease | Mechanical Allodynia | 1.35e-04 | 84 | 172 | 5 | C2936719 | |
| Disease | Hyperalgesia, Secondary | 1.35e-04 | 84 | 172 | 5 | C0751212 | |
| Disease | Hyperalgesia, Primary | 1.35e-04 | 84 | 172 | 5 | C0751211 | |
| Disease | Hyperalgesia, Thermal | 1.35e-04 | 84 | 172 | 5 | C0751214 | |
| Disease | Tactile Allodynia | 1.35e-04 | 84 | 172 | 5 | C0751213 | |
| Disease | Hyperalgesia | 1.35e-04 | 84 | 172 | 5 | C0020429 | |
| Disease | apolipoprotein B measurement | EHBP1 ACACB BCAT2 HMGCR MLYCD ZPR1 PCIF1 PLCG1 B4GALNT3 TAF13 HYDIN CCDC93 SYMPK | 1.47e-04 | 663 | 172 | 13 | EFO_0004615 |
| Disease | very low density lipoprotein cholesterol measurement | 1.52e-04 | 260 | 172 | 8 | EFO_0008317 | |
| Disease | Autistic Disorder | 1.56e-04 | 261 | 172 | 8 | C0004352 | |
| Disease | phospholipids in medium LDL measurement | 1.92e-04 | 49 | 172 | 4 | EFO_0022183 | |
| Disease | cholesterol in medium LDL measurement | 1.92e-04 | 49 | 172 | 4 | EFO_0022224 | |
| Disease | cholesterol in small LDL measurement | 1.92e-04 | 49 | 172 | 4 | EFO_0022227 | |
| Disease | HSAN Type IV | 2.01e-04 | 4 | 172 | 2 | C0020074 | |
| Disease | Hereditary Sensory Radicular Neuropathy | 2.01e-04 | 4 | 172 | 2 | C0086405 | |
| Disease | Hereditary Sensory and Autonomic Neuropathies | 2.01e-04 | 4 | 172 | 2 | C0027889 | |
| Disease | hepatitis (biomarker_via_orthology) | 2.01e-04 | 4 | 172 | 2 | DOID:2237 (biomarker_via_orthology) | |
| Disease | in situ carcinoma (is_marker_for) | 2.40e-04 | 21 | 172 | 3 | DOID:8719 (is_marker_for) | |
| Disease | total lipids in medium LDL | 2.43e-04 | 52 | 172 | 4 | EFO_0022180 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 2.61e-04 | 53 | 172 | 4 | EFO_0022340 | |
| Disease | Colonic Neoplasms | 2.76e-04 | 152 | 172 | 6 | C0009375 | |
| Disease | Acute Cerebrovascular Accidents | 2.81e-04 | 54 | 172 | 4 | C0751956 | |
| Disease | Prostatic Neoplasms | EHBP1 ABCC4 RFX6 MSH3 RRAS PTGS2 PPL SIL1 FAF2 PIK3CD MAPK3 DNMT1 | 2.82e-04 | 616 | 172 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | EHBP1 ABCC4 RFX6 MSH3 RRAS PTGS2 PPL SIL1 FAF2 PIK3CD MAPK3 DNMT1 | 2.82e-04 | 616 | 172 | 12 | C0376358 |
| Disease | alkaline phosphatase measurement | RALGAPA1 CUX2 ACACB BCAT2 FHIP2A ONECUT1 PPL MLYCD ZNF800 PRR14 NWD2 PCIF1 UNC13C B4GALNT3 TNKS2 DNMT1 | 3.11e-04 | 1015 | 172 | 16 | EFO_0004533 |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 3.22e-04 | 220 | 172 | 7 | EFO_0004529, EFO_0008317 | |
| Disease | coronary artery calcification | MAGI1 ANK3 BCAT2 ONECUT1 FSIP2 CLCA2 ZPR1 PCIF1 CADPS2 DNAH6 | 3.28e-04 | 450 | 172 | 10 | EFO_0004723 |
| Disease | Partial Fetal Alcohol Syndrome | 3.34e-04 | 5 | 172 | 2 | C3661483 | |
| Disease | mucositis (biomarker_via_orthology) | 3.34e-04 | 5 | 172 | 2 | DOID:0080178 (biomarker_via_orthology) | |
| Disease | Alcohol Related Neurodevelopmental Disorder | 3.34e-04 | 5 | 172 | 2 | C0814154 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 2 | 3.34e-04 | 5 | 172 | 2 | C0020072 | |
| Disease | pleurisy (biomarker_via_orthology) | 3.34e-04 | 5 | 172 | 2 | DOID:10247 (biomarker_via_orthology) | |
| Disease | Malignant tumor of colon | 3.51e-04 | 159 | 172 | 6 | C0007102 | |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 3.68e-04 | 225 | 172 | 7 | EFO_0008317, EFO_0010351 | |
| Disease | free cholesterol to total lipids in very large VLDL percentage | 3.95e-04 | 59 | 172 | 4 | EFO_0022289 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 4.09e-04 | 229 | 172 | 7 | EFO_0004639, EFO_0008317 | |
| Disease | Brain Ischemia | 4.22e-04 | 60 | 172 | 4 | C0007786 | |
| Disease | Cerebral Ischemia | 4.22e-04 | 60 | 172 | 4 | C0917798 | |
| Disease | Cerebrovascular accident | 4.78e-04 | 62 | 172 | 4 | C0038454 | |
| Disease | Sensory Neuropathy, Hereditary | 4.99e-04 | 6 | 172 | 2 | C0699739 | |
| Disease | Curling Ulcer | 4.99e-04 | 6 | 172 | 2 | C0010474 | |
| Disease | Alcohol Related Birth Defect | 4.99e-04 | 6 | 172 | 2 | C3146244 | |
| Disease | Duodenal Ulcer | 4.99e-04 | 6 | 172 | 2 | C0013295 | |
| Disease | lissencephaly (implicated_via_orthology) | 5.14e-04 | 27 | 172 | 3 | DOID:0050453 (implicated_via_orthology) | |
| Disease | cholesterol to total lipids in medium LDL percentage | 5.14e-04 | 27 | 172 | 3 | EFO_0022238 | |
| Disease | Hyalinosis, Segmental Glomerular | 5.73e-04 | 28 | 172 | 3 | C0086432 | |
| Disease | obstructive sleep apnea (is_marker_for) | 6.36e-04 | 29 | 172 | 3 | DOID:0050848 (is_marker_for) | |
| Disease | amino acid measurement | MPP2 ABCC4 MYH10 BRIP1 ACACB SLC2A7 BCAT2 MLYCD TXNDC16 UNC13C TNKS2 DCLK1 | 6.60e-04 | 678 | 172 | 12 | EFO_0005134 |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 5 | 6.96e-04 | 7 | 172 | 2 | C0020075 | |
| Disease | Schizophrenia | MAGI1 ACSL6 ANK3 ACOT6 GRM8 PTGS2 PITPNM1 DIXDC1 CTNNA2 MAPK3 CADPS2 NOS1 DCLK1 DNMT1 | 7.02e-04 | 883 | 172 | 14 | C0036341 |
| Disease | pulmonary hypertension (is_implicated_in) | 7.04e-04 | 30 | 172 | 3 | DOID:6432 (is_implicated_in) | |
| Disease | resting heart rate, chronic obstructive pulmonary disease | 7.04e-04 | 30 | 172 | 3 | EFO_0000341, EFO_0004351 | |
| Disease | Hereditary Sensory Autonomic Neuropathy, Type 1 | 9.24e-04 | 8 | 172 | 2 | C0020071 | |
| Disease | cystitis (implicated_via_orthology) | 9.24e-04 | 8 | 172 | 2 | DOID:1679 (implicated_via_orthology) | |
| Disease | Aqueductal Stenosis | 9.24e-04 | 8 | 172 | 2 | C2936786 | |
| Disease | Retinitis pigmentosa | 9.34e-04 | 74 | 172 | 4 | cv:C0035334 | |
| Disease | free cholesterol to total lipids in small VLDL percentage | 9.82e-04 | 75 | 172 | 4 | EFO_0022287 | |
| Disease | urate measurement, bone density | MPP2 GALNT18 PPL FSIP2 KIF14 CTNNA2 GFPT2 CADPS2 USH2A DNAH8 DCLK1 | 1.07e-03 | 619 | 172 | 11 | EFO_0003923, EFO_0004531 |
| Disease | brain ischemia (implicated_via_orthology) | 1.11e-03 | 35 | 172 | 3 | DOID:2316 (implicated_via_orthology) | |
| Disease | ovarian neoplasm | 1.16e-03 | 134 | 172 | 5 | C0919267 | |
| Disease | Focal glomerulosclerosis | 1.21e-03 | 36 | 172 | 3 | C0017668 | |
| Disease | Malignant neoplasm of ovary | 1.28e-03 | 137 | 172 | 5 | C1140680 | |
| Disease | exploratory eye movement measurement | 1.31e-03 | 81 | 172 | 4 | EFO_0007700 | |
| Disease | Nerve Degeneration | 1.43e-03 | 83 | 172 | 4 | C0027746 | |
| Disease | transverse temporal cortex volume measurement | 1.47e-03 | 10 | 172 | 2 | EFO_0010336 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.63e-03 | 86 | 172 | 4 | EFO_0008595, EFO_0020945 | |
| Disease | valine measurement | 1.64e-03 | 40 | 172 | 3 | EFO_0009792 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 1.69e-03 | 215 | 172 | 6 | EFO_0008317, EFO_0008591 | |
| Disease | Melancholia | 1.76e-03 | 41 | 172 | 3 | C0025193 | |
| Disease | retinitis pigmentosa (is_implicated_in) | 1.76e-03 | 41 | 172 | 3 | DOID:10584 (is_implicated_in) | |
| Disease | end stage renal disease (is_implicated_in) | 1.76e-03 | 41 | 172 | 3 | DOID:783 (is_implicated_in) | |
| Disease | Depression, Neurotic | 1.76e-03 | 41 | 172 | 3 | C0282126 | |
| Disease | Pancreatic Ductal Adenocarcinoma | 1.79e-03 | 11 | 172 | 2 | C1335302 | |
| Disease | Barrett's esophagus (is_marker_for) | 1.79e-03 | 11 | 172 | 2 | DOID:9206 (is_marker_for) | |
| Disease | Seizures | 1.81e-03 | 218 | 172 | 6 | C0036572 | |
| Disease | resting heart rate | 1.85e-03 | 149 | 172 | 5 | EFO_0004351 | |
| Disease | colitis (biomarker_via_orthology) | 1.89e-03 | 42 | 172 | 3 | DOID:0060180 (biomarker_via_orthology) | |
| Disease | Depressive Syndrome | 1.89e-03 | 42 | 172 | 3 | C0086133 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 2.02e-03 | 43 | 172 | 3 | EFO_0022290 | |
| Disease | triglyceride measurement, very low density lipoprotein cholesterol measurement | 2.07e-03 | 224 | 172 | 6 | EFO_0004530, EFO_0008317 | |
| Disease | hypertrophic cardiomyopathy | 2.09e-03 | 92 | 172 | 4 | EFO_0000538 | |
| Disease | ficolin-3 measurement | 2.15e-03 | 12 | 172 | 2 | EFO_0020392 | |
| Disease | survival time, lung adenocarcinoma | 2.15e-03 | 12 | 172 | 2 | EFO_0000571, EFO_0000714 | |
| Disease | Neurogenic Inflammation | 2.15e-03 | 12 | 172 | 2 | C0600467 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ELRQGVKKPFTEVIR | 51 | P24298 | |
| QPFILRRTKRDVEKQ | 1301 | Q96L91 | |
| VQVEEAIKIFSRPKV | 326 | Q9H0I2 | |
| EIEIKLPKLRTLDVF | 1131 | P26358 | |
| PEQEALEVTRVFLKK | 666 | Q6L9W6 | |
| PNLVNLIEVFRRKRK | 61 | Q5MAI5 | |
| VNIPKRLEEVTLKDF | 616 | Q155Q3 | |
| ITVQKPFLRLSKEDV | 221 | Q8N2C3 | |
| SIEIIIKKNDSPVRF | 251 | Q8WXG9 | |
| DLLKAPQVIRKIRVE | 1471 | Q96L96 | |
| PEKALVRLVKRDVRT | 86 | Q3I5F7 | |
| VTNRIRVKLPKDVDR | 556 | Q6H8Q1 | |
| IKDVARFRPELKVLV | 536 | O60231 | |
| APVKIAVIFKQLRVL | 1321 | Q7Z478 | |
| IELRREFKKNVPEEI | 46 | O14529 | |
| NPLELEQTIRFRKKV | 86 | Q9GZS0 | |
| RILPERFLAVLKQKI | 271 | Q8NBQ5 | |
| KEFIVFLKQDIPLRT | 36 | Q3KRA6 | |
| EQVLSDPNLVIRKRK | 46 | Q9H257 | |
| VKARILPQDVILKFR | 586 | Q96GQ7 | |
| KQITKEFPELVARIE | 96 | O95905 | |
| EKLIKLRDEFIPTIV | 296 | Q9ULI1 | |
| ELVPRRVAIFIEKTK | 306 | Q9P258 | |
| LDQPKLDEVTRRIKQ | 771 | Q8NDT2 | |
| FSRLVEIEPGKRIKL | 46 | Q96DA2 | |
| EALTDKKIPIVRRFV | 366 | Q8HWS3 | |
| GKERVPKQRQVLIFF | 6 | Q9Y5E7 | |
| EALVPILRTFVQSKK | 1436 | O00763 | |
| NPLIQRKEIEREEKF | 91 | Q8N635 | |
| REIPLKVLVKAVLFA | 511 | P35228 | |
| YCRPTVQEERKIVIK | 846 | P20585 | |
| AIRKKIEPEAVLQTR | 706 | Q9H4G0 | |
| PVLIEILQKAEFRTR | 381 | O60684 | |
| VAVRVRPFTKREKIE | 361 | Q15058 | |
| PVFIRKKDRVTVQER | 201 | P55081 | |
| RVQAKIVELRSPLEK | 3926 | Q9NU22 | |
| KVLRFIAEVQKRDPR | 646 | Q9Y5V3 | |
| VRRKVVFAVPKTENE | 921 | Q96QZ7 | |
| QTRNITVDPRLFKKR | 66 | P01138 | |
| EINRIFAKRNRVKLP | 476 | Q6PXP3 | |
| DPDSFRVVKLKRIQR | 481 | Q0VAK6 | |
| ISLFLLKKRERVQIP | 466 | Q7Z3F1 | |
| INRERKVEVIKPLVA | 391 | P04035 | |
| PSQQEIEEALVRRKK | 246 | Q9ULR0 | |
| KIAERIKIFFALAPV | 156 | Q5W064 | |
| FKETERPSIKQVIVR | 681 | Q9NQW6 | |
| NVLRKEETQKRPVDL | 1636 | Q9Y3R5 | |
| PEISVEVLKKVVRYR | 4731 | Q15751 | |
| VRENKDFIRPKLVTI | 176 | O15075 | |
| FLIKRVVKELQREFP | 306 | O95822 | |
| TENPDRVKLKLTRIV | 4971 | Q5CZC0 | |
| RKKPTENVLIFLINR | 26 | P0DPP9 | |
| AKVVVQEKVREIVRP | 1166 | O60437 | |
| KLLVNFDPKILEVVR | 596 | Q96JB1 | |
| VAVRIRPQLSKEKIE | 11 | O75037 | |
| KKPRLVFTDVQRRTL | 386 | Q9UBC0 | |
| LKRLKELEEQVRTIP | 271 | Q14678 | |
| EKIILSERKNVPIEF | 1531 | Q5S007 | |
| NEIVEKLLLRRKFIP | 161 | P35354 | |
| TRTIIQKEPIDLRVK | 216 | P32004 | |
| PLALVEEIRNRKDVK | 151 | Q9BSD7 | |
| PKERLKELIFQETAR | 356 | P27361 | |
| LIPSQLLEEKRKAFV | 306 | Q14168 | |
| KKFVTELRRPVAVRA | 766 | Q5XXA6 | |
| RPRTRAQKVEVKEEL | 2841 | P46013 | |
| EIRRQKERITEQPLK | 126 | Q8TAM6 | |
| EFEKIIKRLLETPNA | 261 | O00222 | |
| PGIVKILFEVVRKDE | 331 | Q86Y13 | |
| LQKAFEIAKRIPIIT | 196 | P55082 | |
| IQPNVISVRLFKRKV | 11 | P29475 | |
| AKFKEVIPITNSELR | 246 | Q6ZMV5 | |
| VQGPREVKKRELVFL | 171 | Q9H813 | |
| VEKKRIRPLETTQQI | 156 | Q9BX63 | |
| LRVSEPKVVFAKEQL | 881 | Q5VST9 | |
| NVDPRTDELIQKKIR | 1206 | O15439 | |
| IKTVVDLSEVYKPRR | 166 | Q567U6 | |
| PKDVIRKDVRAILNR | 1301 | Q14008 | |
| YSRVVKVVEPKRQKL | 2891 | Q9C0G6 | |
| VVRLEKPRLEEQRIK | 3206 | Q9C0G6 | |
| RKTPVIVTLKENERF | 66 | Q9Y4L1 | |
| RIPIKFVSNLKNVRV | 416 | Q8N9C0 | |
| ILRNNDKIPRLVKVV | 121 | Q4G0P3 | |
| LRAELKPKTRIFEIQ | 1756 | Q4G0P3 | |
| KPQRFRVIVEILKPE | 4756 | Q4G0P3 | |
| RLIKSRELEFVEQPK | 801 | Q6ZP82 | |
| IPIRLSRIKFREEAK | 271 | Q9H4Z3 | |
| SEISKLIVPIYEKRR | 1716 | Q5JSL3 | |
| LVKREKPEEFQTRVR | 916 | P26232 | |
| RVPRTRKEIFETLIK | 11 | O94808 | |
| EPEEKRRKIANVVIN | 241 | O14981 | |
| VDPVFTREVKAKVKR | 206 | Q96MS3 | |
| KIRSPNIRVKAVFRE | 111 | Q8TD84 | |
| LRKRRVVIVDPETNK | 2461 | P15924 | |
| RENKDFVRPKLVTII | 171 | O43602 | |
| KLRLKEAPNISREVV | 86 | O95390 | |
| LRERKVVVIDTPDLF | 56 | Q8ND71 | |
| AEPVLTRIKENRKRI | 261 | Q6P9A2 | |
| LFVTLRRQKKEPLIV | 636 | P55287 | |
| EERQKRVLKPAIALQ | 2061 | Q12955 | |
| VFKKNIEKRVRSLPE | 176 | Q86UW7 | |
| RKPRLELQIKEVDEF | 591 | Q6ZMT9 | |
| NPVQELETERRVKRK | 386 | Q8NDI1 | |
| KDRNKLFPESVIRNI | 91 | P20794 | |
| RSRAIIKPVIVDKDV | 751 | Q86V48 | |
| RKKPTENVLIFLINR | 26 | Q3ZM63 | |
| QRVPDKRVIIKDLQL | 151 | Q8NFN8 | |
| DVSRIIKKPDLRIIE | 6251 | Q8NDH2 | |
| QRIQDFTPKLLLVRK | 706 | Q5W0V3 | |
| RPDIAALVRQVIIKK | 191 | Q8TED1 | |
| PELILRFQKELKEIQ | 366 | O15382 | |
| LPLTKTEEQILKRVR | 141 | O43889 | |
| PVGKREIFITFRVQK | 321 | Q96EY1 | |
| IQKVVPITNKLFVRL | 501 | Q9Y597 | |
| PIVLFIRVCEKNIKR | 1071 | Q9BXL7 | |
| IIAEKVKDVLFIRPR | 96 | Q92613 | |
| RVFTKVKPLLQVTRQ | 836 | P35580 | |
| PVRNVYKKEKARVIT | 156 | P26373 | |
| ILQERELLPVKKFES | 381 | Q08211 | |
| RQIEERKKQLSFISP | 151 | O43395 | |
| RPFKQRKSLAIRQEE | 11 | Q9BXW4 | |
| FRLQEPKKDLIARVV | 236 | Q9H814 | |
| KFKLLEQARDVREPV | 86 | Q75VX8 | |
| KAIIKEKQPFERLEV | 286 | A2RTX5 | |
| TILRKDPEIIQKGFV | 1656 | O75445 | |
| VPLTFLFVDRKLQRV | 231 | O75677 | |
| RKEVELIVQEKPFTV | 301 | P19320 | |
| KEPFVELNRILEALK | 151 | Q9H871 | |
| EVFKPENISLRNKLR | 46 | Q9UPR3 | |
| DRLLVPQVAIKKDFT | 441 | Q86VY9 | |
| PIIRAQVRDTLKIVF | 421 | P12259 | |
| PKFEEILTRLRLQKR | 306 | P06732 | |
| EILRLIQFEPQKVKE | 181 | P35243 | |
| KKCIREPRFVEVLLQ | 281 | Q8IVG5 | |
| SVKIIFKLPNDSRVE | 361 | Q96CS3 | |
| RPIRLNKKEFSLEEI | 466 | Q9BWN1 | |
| IPEDQRLQRTEVVKK | 31 | O43663 | |
| VLITPLEKFRKEQIG | 111 | Q9UNA1 | |
| KARQAEVKRLFRPIE | 151 | Q9H173 | |
| FTKRVRIIEPLLVFL | 271 | Q14940 | |
| VQVEDIVFLIRKDPR | 81 | Q15543 | |
| KALRVVKFPDLDRNV | 91 | Q9NTN3 | |
| IRELNLIIKVFREPF | 216 | Q07889 | |
| VKVIRSPADLIRFIE | 356 | Q13438 | |
| RTVPVKIDKVRIFLL | 301 | Q9UHB9 | |
| VRGLQVFKERIKAPV | 81 | Q9NSD9 | |
| QKLIITEETAKIRPF | 106 | Q9NSD9 | |
| KIRPFAVAAVLRNIK | 116 | Q9NSD9 | |
| RVEIKDVKLPVQLQR | 191 | P27105 | |
| REIIVEKSKAVRVLP | 321 | Q5VYV7 | |
| EKLEEQRPERVKLFI | 101 | Q9HAU6 | |
| LKPEQVERLIKEFSI | 386 | P00505 | |
| LKVTEKVIFPRQDDV | 301 | Q9UKU0 | |
| TKRRVFFRNIKILIP | 76 | Q9UQC9 | |
| RLFTKVKPLLQVTRQ | 836 | P35749 | |
| KIIIRQPIRTEYKIA | 301 | Q6P2Q9 | |
| DKDFVIVRRPKLNRE | 76 | Q13309 | |
| VAFILRQVIEKERPQ | 871 | O00562 | |
| AETDLPVVFVKQRKI | 116 | Q16881 | |
| KFRKDIIRILPSLDV | 236 | Q8N1K5 | |
| RLLLTKIPFFREIIV | 61 | O75312 | |
| VAETVFRDRKRKLPL | 376 | Q9P2K2 | |
| ILEPFTVERAKVNKE | 801 | Q6GYQ0 | |
| KIREKNRPEVFEVIQ | 1176 | Q8NB66 | |
| EIRTVLEKLRPLDQK | 91 | Q8NEJ9 | |
| KVVPDVGKVFRLEVV | 111 | P49675 | |
| RRLEPAIQKFIKIVI | 11 | P56962 | |
| VVSKPDLITFLEQRK | 46 | Q14586 | |
| KREARQILDQTPVKE | 341 | Q9H1D0 | |
| LRKKATVFRQPLVEQ | 221 | O00329 | |
| PERKTFQVKLETRQI | 46 | P19174 | |
| EFVPLRTKAKEILQE | 471 | P38606 | |
| KIRERNKPEIFEVIR | 556 | O14795 | |
| KVRQLIPIFTDVALK | 446 | Q9UKN8 | |
| EPKLTQVYKNVRERI | 1491 | Q14997 | |
| PLKRVIVRKVVESAE | 16 | Q8NB14 | |
| DVERVKRLVTPEKVN | 36 | Q9H2K2 | |
| IKLNPIVVKEVFNRL | 911 | Q92797 | |
| RVDRLQVKVTQLDPK | 71 | Q9Y6W5 | |
| LEIRAIKKPIDFVLN | 556 | Q2TB10 | |
| ELPRVSALEVKQRRK | 56 | Q2M2D7 | |
| KSVLIRQQILPREKT | 171 | O60765 | |
| ILRVKDRDDFPVVLV | 126 | P10301 | |
| VNTFKVLTRDKRLVP | 396 | P50990 | |
| KREARQILEQTPVKE | 301 | Q9NQA5 | |
| TTIQFKLEKIPIERE | 1491 | Q5THJ4 | |
| SVVLKKVREEIFNPL | 586 | P20592 |